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ABSTRACT 
Depo-Provera, an injectable contraceptive, is utilized by about 30% of married women in Malawi. 
Most women have reported their preference to use Depo-Provera due to its effectiveness in 
preventing pregnancy, reversibility and easy to use since it is given once at 12-weeks intervals. 
Despite the method having such advantages, it has menstrual effects, and one of the major concerns 
for women, particularly in Africa, is amenorrhea. In Malawi, 40% of Depo-Provera users report 
experiencing amenorrhea after one year of use. Despite the concern for amenorrhea, some women 
have continued using the method. Literature shows that there is limited information on women’s 
experiences of amenorrhea following use of Depo-Provera. A descriptive phenomenological 
research design was used to explore and describe women’s experiences of amenorrhea following 
use of Depo-Provera in order to understand how women experience amenorrhea and give meaning 
to the experience. Data were collected through in-depth unstructured interviews with six women, 
who were selected using purposive sampling. The interviews were conducted in Tumbuka 
language. Data analysis was done using Colaizzi’s method of analyzing descriptive 
phenomenological data.  
Five themes and some sub-themes emerged from data analysis. The themes were: “Lack of 
knowledge on cause of amenorrhea”, “Fear of pregnancy”, “Misconceptions associated with Depo-
Provera Induced Amenorrhea”, “Lack of proper counseling on amenorrhea resulting from Depo-
Provera use” and “Amenorrhea not perceived as a problem when midwives provide adequate 
information”. The themes showed that women accessing family planning services from Chitipa 
district hospital were not provided with information on amenorrhea resulting from using Depo-
Provera. Hence, they expressed fear when they experienced the side effect. Participants stated that 
they were afraid of becoming infertile after using the family planning method, getting pregnant as 
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well as amenorrhea itself. Their intention to discontinue using the method was largely associated 
with negative rumors, beliefs and misconceptions. The conclusion of the study is that there is need 
for midwives to provide information on amenorrhea resulting from Depo-Provera use. This will 
assist clients to understand that amenorrhea could occur as a side effect, and hence improve 
continued utilization of the method.  
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CHAPTER 1 
ORIENTATION TO THE STUDY 
 
1.0 INTRODUCTION AND BACKGROUND 
According to Husain, Dutta and Ghosh (2011), family planning refers to the use of contraceptive 
methods to achieve preferred number of children and ensure the desired timing of conception and 
spacing between births. There are two major categories of family planning; modern and traditional 
methods. Modern methods comprise male and female condoms, implants, intrauterine devices 
(IUD), injectable contraceptives, male and female sterilization, oral pills and spermicides. 
Traditional methods include withdrawal, periodic abstinence, rhythm method and breastfeeding 
(Maliwichi-Nyirenda & Maliwichi, 2010). 
Depo-Provera, an injectable contraceptive method, was developed by Upjohn Company in 1954, 
for management of endometriosis and habitual or threatening abortions (Seth, Nagrath, & 
Deoghare, 2012). In 1960 it was discovered that women with premature labor who were given 
Depo-Provera had a noticeable delay in getting pregnant after giving birth (Seth et al., 2012). This 
prompted development of Depo-Provera as an agent for regulating fertility (Seth et al., 2012). In 
1967, Upjohn submitted an application for approval of Depo-Provera as a human contraceptive to 
the Food and Drug Administration (FDA). Concurrently, the company filed a contraceptive 
product license in various countries between the years 1966 to 1969. All requests for use of Depo-
Provera as a contraceptive in humans were approved (Richard & Lasagna, 1987). In 1972, the 
FDA rescinded its approval of Depo-Provera due to subsequent efficacy studies and concerns that 
highlighted the contraceptive’s effects of possible teratogenicity and delayed return to fertility 
(Richard & Lasagna, 1987). However, by 1980, Depo-Provera had been approved in more than 80 
countries (Westhoff, 2003).  
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Depo-Provera is given once at 12-weeks interval in a 150 mg dose. It is made up of progestin, 
known as Medroxy-progesterone. The first injection is usually given within the first seven days of 
menstruation and it has an immediate contraceptive effect (Tolley et al., 2014; Fraser, Cooper, & 
Nolte, 2010). Depo-Provera prevents pregnancy by inhibiting ovulation, halting implantation of 
the fertilized ova and forming a mucous pad in the cervix to deter passage of sperms into the uterus 
(Bagade et al., 2014). According to Fraser et al. (2010), when Depo-Provera is discontinued, there 
may be an 18 months’ delay in return of fertility. 
Depo-Provera has advantages such as easy reversibility, use and effectiveness. Despite having 
such advantages, it has side effects, the major one being amenorrhea (Castle, 2003). Worldwide, 
approximately 12% of Depo-Provera users report experiencing amenorrhea after three months of 
use, 25% after six months of use, 37% after nine months of use, and 46% after one year of use 
(Hubacher, Lopez, Steiner, & Dorflinger, 2009). According to Mohebbi-kian, Mohammad-
Alizadeh-Charandabi and Bekhradi (2014), amenorrhea was reported by approximately 60% and 
80% of Depo-Provera users in Iran, by the end of the first and third years of use, respectively. 
The Malawi Demographic and Health Survey (MDHS) indicated that modern family planning 
methods being offered in Malawi’s health facilities include oral pills, injectable contraceptives, 
male and female condoms, implants, IUDs, male and female sterilization, and emergency 
contraception (MDHS, 2010). In Malawi 59% of married women are utilizing a contraceptive 
method, and 58% of these women use a modern contraceptive method (National Statistical Office 
[NSO] & Inner City Fund [ICF] International, 2016). Among the modern contraceptive methods, 
Depo-Provera is utilized by about 30% of married women, and 15% of sexually active unmarried 
women, making it the most popular method in Malawi (NSO & ICF International, 2016). 
According to the NSO and United Nations Children’s Fund (UNICEF) family planning services 
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in Malawi were mainly hospital-based until in 2008, when the population increased from 
approximately three million in late 1960s to about 13 million (NSO & UNICEF, 2008). The 
Ministry of Health (MOH) in collaboration with Sexual and Reproductive Health (SRH) 
stakeholders stepped up efforts to expand the services from being hospital-based to being a 
Community-Based Distribution (CBD) program (MOH, 2012). Accordingly, the Ministry changed 
its policy and allowed Health Surveillance Assistants (HSA); who are government employed 
community health workers, to provide Depo-Provera at community level. This resulted in an 
increased utilization of Depo-Provera in the country (MOH, 2012). According to Clark, Barnes-
Harper, Ginsburg, Holmes and Schwarz (2006), some women indicate poor adherence to the 
method due to their experience of amenorrhea following its use.  
 
1.1 PROBLEM STATEMENT 
In Malawi, 40% of women report experiencing amenorrhea after using Depo-Provera for a year 
(Sangala, 2014). Despite Depo-Provera induced amenorrhea being perceived as an advantage by 
some women in western countries, such as the United States (Mohebbi-kian et al., 2014), it is one 
of the major reasons why most women in Malawi discontinue using the contraceptive method 
(Lema, Mtimavalye & Gondwe, 1994). In a study done at Queen Elizabeth Central Hospital in 
Malawi in 1993, Lema et al. (1994) indicated that absenteeism to family planning clinic was as 
high as 29%, and this was largely attributed to side effects such as amenorrhea when it was not 
included in counseling.  
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1.2 SIGNIFICANCE OF THE STUDY 
Despite that amenorrhea is one of the major reasons why most women in Africa discontinue using 
Depo-Provera there is limited information on women’s experiences of the phenomenon, hence the 
need to conduct this study. The findings of the study have the potential to convey knowledge that 
will aid health care workers, particularly midwives and policy makers, to better understand 
women’s experiences of amenorrhea following Depo-Provera use and the meaning attached to the 
phenomenon.  
 
1.3 RESEARCH QUESTION 
The research question for this study was: 
 How do women utilizing family planning services at Chitipa District Hospital in Malawi 
experience amenorrhea following Depo-Provera use? 
 
1.4 PURPOSE OF THE STUDY 
The purpose of the study was to explore and describe women’s experiences of amenorrhea 
following use of Depo-Provera as a contraceptive method at Chitipa District Hospital in Malawi. 
This was in order to gain a better understanding of how women experience and give meaning to 
the phenomenon. 
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1.5 RESEARCH OBJECTIVES 
The objective for this study was: 
 To explore women’s personal experiences of amenorrhea following use of Depo-Provera 
as a family planning method at Chitipa District Hospital in Malawi. 
 
1.6 OPERATIONAL DEFINITIONS 
Amenorrhea: the absence of menstrual bleeding for more than three of the last menstrual cycle 
intervals or for six months (Wellons & Rebar, 2013). In this study, amenorrhea has been defined 
as the absence of menstrual bleeding for more than a year due to Depo-Provera use, in a woman 
previously with normal menstruation. 
Contraception: a conscious effort by a couple to limit or space the number of children they intend 
to have by use of family planning methods (NSO & ICF International, 2016). In this study 
contraception refers to a means of preventing a woman from becoming pregnant by use of Depo-
Provera, and it has been used interchangeably with family planning.  
Contraceptive Counseling: the utilization of interactive communication skills to effectively 
transfer information that will help to assist a woman decide on her family planning needs 
(Kittisiam, Werawatakul, Nanagara & Wantha, 2013). In this study contraceptive counseling refers 
to a process of sharing contraceptive information between a family planning provider and a Depo-
Provera contraceptive user. 
Depo-Provera: a three-monthly hormonal injectable contraceptive method. It does away with 
monthly bleeding in a number of women by preventing cyclical ovarian activity (Glasier et al., 
2003). 
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Discontinuation: when a woman stops using a contraceptive method due to side effects or spousal 
influence (Bagade, et al., 2014). In this study discontinuation has been defines as when a Depo-
Provera contraceptive user stops using the method as a result of experiencing amenorrhea. 
Women of child bearing age: women aged between 15-49 years (Chitipa District Socio-economic 
Profile, 2007). 
 
1.7 BACKGROUND OF STUDY AREA 
1.7.1 MALAWI 
Malawi is found in Sub-Saharan Africa between the borders of Tanzania, Mozambique and Zambia 
(NSO & ICF Macro 2011).  According to the World Bank report of 2012 Malawi is rated as one 
of the poorest nations in the world, with a population of approximately 15.38 million (as cited in 
NSO & ICF Macro, 2011). Nearly 49% of this population is under the age of 15 (NSO & ICF 
Macro 2011). Malawi is one of the most densely populated nations in the world (Malawi 
Government, 2012; World Health Organization [WHO], 2011).   
According to NSO and ICF Macro (2011), Malawi is divided into three regions, which comprise 
a combined total of 28 districts. The northern region, which has a population of about 13% of the 
total population, is said to have the best socio-economic indicators when compared to southern 
and central regions. The central region, which has nearly 42% of the country’s population, has the 
second best socio-economic indicators. The southern region is rated as the least developed of the 
three regions and has 45% of the Malawi’s population (Malawi Government, 2010). 
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 Figure 1:  Map of study area   
  
Malawi as a country experiences socio-economic challenges which are worsened by the fast 
growing population. In 2012 Malawi registered a population growth rate of about 2.8% annually 
and the rapid growth rate is as a result of the high fertility rate, at 5.7 children per woman, and a 
drop in mortality rate (Malawi Government, 2012). Some of the consequences of the rapid 
population growth include depletion of natural resources, high unemployment rate amongst the 
youthful generation, poor infrastructure and food insecurity (Malawi Government, 2012). In 
addressing challenges arising from overgrowing population, Malawi has adopted contraceptive 
use as a tool to tackle population related challenges (Cohen, 2000).    
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Malawi has a high infant and maternal mortality rate, which echoes the impact and magnitude of 
poverty and poor socio-economic conditions (NSO & ICF Macro, 2011). Maternal mortality nearly 
doubled between 1992 and 2000 at 620 and 1120 per 100 000 live births, respectively (NSO & 
ICF Macro, 2011). However, there has been a decline in maternal deaths to 675 per 100 000 live 
births in 2010, while the infant mortality is at 66 per 1000 live births (NSO & ICF Macro, 2011). 
According to NSO and ICF Macro (2011), these indicators are a reflection of lack of access to, 
and poor coverage of maternal health services.  
 
1.7.2 CHITIPA DISTRICT (RESEARCH SETTING) PROFILE 
Chitipa district is situated to the northeast of the Northern Region of Malawi. The district is 
bordered by Tanzania to the north and Zambia to the east. Locally Chitipa district is bordered by 
Rumphi District to the south as well as Karonga District to the northeast (Chitipa District Socio-
economic Profile, 2007). The district is situated approximately 400km from Mzuzu, the 
commercial capital for the northern region, and 700km from Lilongwe which is the capital city of 
Malawi (Chitipa District Socio-economic Profile, 2007).  
1.7.2.1 HEALTH 
Chitipa District has 82 health facilities, and of these 73 are health posts, eight are health centers 
and one is a hospital, which is the district hospital. Of the health posts 41 are established with 
permanent structures while 32 are non-established, and have no permanent structures (Chitipa 
District Socio-economic Profile, 2007). The Malawi Government owns all the health facilities 
except two health centers which are owned by Christian Health Association of Malawi (CHAM). 
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Chitipa District Hospital acts as a referral facility for the district despite not being centrally located. 
The hospital is located at approximately 120km to the furthest health center (Nthalire), and lies 
27km to the nearest health center (Ifumbo). It is also located at about 44km to the neighboring 
Karonga District border and 7km to Zambian border (Chitipa District Socio-economic Profile, 
2007). The eight health centers in Chitipa District are situated in all the five Traditional 
Authorities, namely Nthalire, Mwaulambia, Mwenewenya, Mwenemisuku and Kameme. These 
health centers offer antenatal, family planning, maternal and neonatal services among others 
(Chitipa District Socio-economic Profile, 2007). According to NSO and ICF Macro (2011), 18.7% 
of women are utilizing Depo-Provera as their preferred method of contraception, making it the 
most utilized contraceptive method. 
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Figure 2: Map of Health Facilities in CHITIPA (Source: Chitipa District Socio-economic  
Profile, 2007) 
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1.8 CONCLUSION 
This chapter focused on introduction and background to the study, problem statement, and 
significance of the study, research question and objective, purpose of the study as well as 
operational definitions. The chapter also highlighted the background of the study area. The next 
chapter will focus on literature review, highlighting research studies that are related to the current 
study. 
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CHAPTER 2 
LITERATURE REVIEW 
2.0 INTRODUCTION 
This chapter focuses on qualitative and quantitative study findings related to the topic of the study. 
The literature review was mainly done to familiarize the researcher with the phenomenon of Depo-
Provera induced amenorrhea, and to integrate the research study with previous related studies. The 
following databases: Google Scholar, EbscoHost, PubMed, Sabinet and Scopus were used to 
search for literature. The review revealed that there is limited information on women’s experiences 
of amenorrhea following Depo-Provera use. However, studies have been published on women’s 
views of amenorrhea induced by contraception, mainly progestin only containing contraceptives, 
of which Depo-Provera is a typical example. Some studies have highlighted amenorrhea as a 
reason for women discontinuing use of Depo-Provera.  
 
2.1 POPULARITY OF DEPO-PROVERA 
Worldwide, above 40 million women are using Depo-Provera to prevent pregnancy (Tolley et al., 
2014), and its use doubled between 1995 and 2005 (Lande & Richey, 2006). According to Spevack 
(2013) over two million women in the United States of America (USA), including about 400,000 
adolescents are utilizing Depo-Provera annually. The advantages of Depo-Provera relates to the 
fact that it only needs one injection every 12 weeks, it offers prolonged protection against 
pregnancy as a result of crystallized progestin which dissolves into the blood stream slowly, and 
it is 99% effective at preventing pregnancy when used appropriately (Speroff & Darney, 2010; 
Hatcher, Trussell, & Nelson, 2004). The proportion of women utilizing modern family planning 
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methods in Sub-Saharan African region has improved in approximately all countries in the region 
over the past two decades. The Sub-Saharan Africa has recorded minimum rate of Depo-Provera 
use worldwide due to amenorrhea which is still a concern to African women (Adetunji, 2013). 
According to NSO and ICF International (2016), Malawi has recorded a 30% use of Depo-Provera 
by women, making it the most widely used method when compared to other contraceptive 
methods. In Chitipa, one of the districts in Malawi, 18.7% of married women use Depo-Provera 
as their preferred contraceptive method (NSO & ICF Macro, 2011).  
 
2.2 AMENORRHEA AND DISCONTINUATION 
Depo-Provera is a highly effective contraceptive method. However, the rate of discontinuation 
continues to be remarkable among women mainly due to amenorrhea (Gholamitabar Tabari, 
Moslemi, Esmaelzadeh, & Bijani, 2012). According to Littlejohn (2013), there have been negative 
experiences with side effects in women’s annoyance with Depo-Provera and its consequent 
inconsistent use. Higher discontinuation rates have been recorded in other parts of Africa. For 
example, a longitudinal mixed research study involving 259 women, to determine impact of 
amenorrhea on contraceptive discontinuation in Egypt found a 70% discontinuation rate for Depo-
Provera (Tolley, Loza, Kafafi, & Cummings, 2005). Much as it is accepted that Depo-Provera is 
the most used contraceptive method, most studies cite amenorrhea as the common reason for 
discontinuation of the method. In a study done in Turkey, most women discontinued Depo-Provera 
due to amenorrhea, and this was attributed to poor socio-economic and educational status of 
Turkish women involved in the study. It was then concluded that reassuring women that Depo-
Provera induced amenorrhea is not equivalent to sterility or being pregnant and that it is a usual 
sign among users would reduce method discontinuation (Aktun et al., 2005). 
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In a retrospective observational cohort study carried out on Turkish women (N=9, 262) treated 
with Depo-Provera, 71% (6, 576) discontinued the method (Aktun et al., 2005). According to 
Ntupanyama (2009), in her study to evaluate FP client assessment process in health centers in 
Blantyre District of Malawi, the SSA records the minimum rate of Depo-Provera use worldwide 
due to amenorrhea which was a concern to most women. In an analysis of about 18 DHSs, a United 
Nations (UN) report of 2006, had estimated the median one-year probability for discontinuity of 
Depo-Provera at 46% compared to 36% and 12% for oral contraceptives and intrauterine devices 
respectively. Most of the reasons for discontinuation were side effects such as amenorrhea 
(Weinreb, 2013).  
According to Foreman and Spieler (2013) infertility may not come as a result of using Depo-
Provera, but there is a delay in the period that a woman takes to become pregnant after 
discontinuation.  
In a questionnaire survey of 1,001 clients and 290 family planning providers in four countries of 
China, South Africa, Nigeria and Scotland, more contraceptive providers were of the view that it 
was significant for women to have their menses while utilizing Depo-Provera. In all the centers of 
the survey, approximately 75% of the providers thought that women whom they serve considered 
having menses following Depo-Provera use as being very significant too (Glasier et al., 2003). 
Having menses was viewed as normal by women; a means of releasing bad blood and an indication 
of fertility, whereas amenorrhea denoted ovarian failure, as well as an indication of the end of 
reproductive potential (Glasier et al., 2003). In another questionnaire survey involving women 
(N=5,000) conducted in ten countries (Indonesia, Egypt, Jamaica, India, Mexico, Korea, 
Philippines, United Kingdom (UK), Pakistan and Yugoslavia), most women from all cultural 
backgrounds were reluctant to accept a family planning method that would cause amenorrhea after 
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its use (WHO, 1981). This was indicated by about 50% of the women in Korea, 53% in the UK, 
85% in India and 91% in Pakistan (WHO, 1981). Women who participated in the survey expressed 
the feeling that amenorrhea following Depo-Provera use was unnatural, with menstruation being 
viewed as an outlet for bad blood (WHO, 1981).  
Despite amenorrhea being perceived as an advantage by some women in the western countries, it 
is still one of the major reason why most African women are discontinuing use of Depo-Provera 
(Mohebbi-kian et al., 2014).   
 
2.3 CLIENT AND MIDWIFE INTERACTION 
According to Dehlendorf, Kimport, Levy, and Steinauer (2014), interaction between a client and 
a midwife during family planning visits has a great influence on women’s contraceptive use. With 
informed choice, a midwife is obliged to share information about Depo-Provera including possible 
occurrence of amenorrhea following its use. In a qualitative analysis of approaches to 
contraceptive counseling done on 342 women visiting family planning providers at various clinics, 
Dehlendorf, Levy, Kelley, Grumbach, and Steinauer (2013) revealed that understanding of 
information provided by family planning providers was one of the most common priorities for 
women in counseling sessions. Similarly, qualitative interviews involving women to examine 
fears, knowledge acquisition and decision making in three countries of India, Nigeria and Nepal, 
showed that women who were told that amenorrhea would not cause any harm to their reproductive 
life, were more likely to use the injectable method (Diamond-Smith, Campbell, & Madan, 2012). 
Lack of knowledge on Depo-Provera use and its resultant amenorrhea is one of the factors 
contributing to its contraceptive failure in Africa (Sattari, Mokhtari, Jabari, & Mashayekhi, 2013).  
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Fisher and Black (2007) recommended that health care providers need to provide women with 
accurate and relevant information about amenorrhea following Depo-Provera use to enable them 
initiate and maintain use of the method.  
Counseling on contraception is a medium through which a woman’s plan as regards the decision 
to have, space and number of children is discovered, and that these are influenced by cultural and 
religious beliefs, her individual feelings, wishes and expectations, as well as environment, 
including her experience (Nobili, Piergrossi, Brusat, & Moja, 2007). The main aim of offering 
counseling on contraception is to provide non-judgmental, precise information and facts regarding 
the obtainable family planning methods to assist the woman examine her needs and the make an 
informed choice among the many (Madden, Mullersman, Omvig, Secura, & Peipert, 2013). It is 
therefore significant that the client knows what is best of all the contraceptive methods including 
Depo-Provera, as this enhances her preferred choice as regards contraception. Most women 
become concerned that family planning providers do not explain to them necessary information 
regarding Depo-Provera use, including side effects (Dehlendorf et al., 2013). Family planning 
providers need to emphasize on the after effects of being on a particular method, so that women 
should not be surprised when faced with such effects (Dehlendorf et al., 2013) . According to 
Carneiro Gomes Ferreira, Impieri Souza, Evangelista Pessoa, & Braga (2011) an individualized 
contraception counseling aims at stimulating clients to enable them withstand their feelings, 
concerns, beliefs and expectations and should lead them to constructively come up with good 
decisions as regards family planning choices. This includes an understanding of side effects that 
may be encountered while using Depo-Provera. 
Women who are not informed about potential side effects of Depo-Provera are more likely to 
switch from using the injectable to other contraceptive methods. According to Jaccard and Levitz 
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(2013) switching a contraceptive method entails changing to another method as a result of limited 
information regarding side effects of all effective and available contraceptive methods including 
Depo-Provera (Jaccard & Levitz 2013). In-depth health information on contraception , therefore, 
offers wise beneficial direction on the woman’s preferred choice of contraception, which would 
not have happened if such information was concealed (Egarter et al., 2012).  
Family planning providers need not influence clients on their decision regarding contraception as 
this would have skewed her decision towards that of the provider (Gemzell-Danielsson et al., 
2012). According to Harper et al. (2013) a family planning clinic must be regarded as a crucial 
place where health information and counseling is offered to enable clients make informed choices 
on which contraceptive method to use (Harper et al., 2013). Nobili et al. (2007) indicated that the 
counseling on family planning is valuable in raising awareness and utilization of methods of 
contraception among women. In addition, counseling on contraception enhances efficient 
contraceptive use at a later time (Nobili et al., 2007). 
 
2.4 CONCLUSION 
This chapter presented the literature review, which highlighted the popularity of Depo-Provera as 
a contraceptive method, how amenorrhea has impacted the use of Depo-Provera by women, 
particularly in Africa and the impact of the care provider on the utilization of family planning 
methods, specifically Depo-Provera. The next chapter highlights the methodology of the study, 
which includes: the research design, setting of the study, population, sampling and sample size, 
data collection process and data analysis process.  
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CHAPTER 3 
RESEARCH METHODOLGY 
3.0 INTRODUCTION 
This chapter focuses on the methodology and methods that were used for the study. They include: 
the research design, setting, population, sampling and sample size, data collection and analysis. 
The chapter also highlights the limitations for the study and plan for dissemination of findings. 
 
3.1 QUALITATIVE RESEARCH APPROACH 
Qualitative researchers study things in their natural settings. They try to make sense of phenomena 
regarding the meanings that individuals attach (Goyal, 2010). Since qualitative research focuses 
on the social reality of people, groups and cultures, it is used in the exploration of behavior and 
perspectives as well as experiences of individuals being investigated. Thus, it was found 
appropriate for this study whose aim was to better understand the meaning that women who are 
using Depo-Provera attach to their experience of amenorrhea. Behavior is interpreted by the way 
in which individuals interpret and make sense of their subjective reality, thus qualitative research 
is rooted in the interpretive approach to social reality (Goyal, 2010).  
 
3.2 RESEARCH DESIGN 
The study utilized the descriptive phenomenological design based on the works of Edmund Husserl 
(2012). 
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3.2.1 PHENOMENOLOGY 
Phenomenological research is based on the work of Edmund Husserl’s (2012) philosophical work 
and focuses on comprehending participants’ lived experiences (as cited in Chan, Fung, & Chien, 
2013). Husserl is widely known as the father of phenomenology, the science of consciousness.  
According to him, information and insight do not emerge from large amounts of data, but comes 
from an in-depth study of experiences, conducted through the phenomenological method (Husserl, 
2012). Goyal (2010) defines phenomenology as a philosophical approach to the study of 
phenomena or appearances as well as human experience. According to Langdridge (2007) 
phenomenology is an approach to qualitative research with the specific focus of identifying the 
intrinsic and unchanging meaning of the phenomenon under investigation. Embree (1997) 
described seven approaches to phenomenology. However, this research study is guided by 
descriptive (transcendental) phenomenology since it seeks to understand the meaning that people 
attach to a particular experience, and it is a design that enables researcher to acquire and collect 
data that explicates the essence of human experience (Moerer-Urdahl & Creswell, 2004). 
Phenomenological researchers are interested in the subjectivity of other individuals and hence the 
need to get a description of such subjectivity (Englander, 2012). According to Wojnar and 
Swanson (2007), descriptive phenomenology calls for exploration of phenomenon through direct 
interaction between investigator and object of study.  
Phenomenology entails the use of thick description and close analysis of lived experiences in order 
to understand how meaning is attached to a particular phenomenon under study, and that this is 
done through embodied perception (Sokolowski, 2000). According to De Vos (2011), a 
phenomenological study describes the meaning of lived experiences of a particular phenomenon 
for a number of individuals. Starks and Trinidad (2007) explains that phenomenology contributes 
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to deeper understanding of the lived experiences by exposing taken-for-granted assumptions as 
ways of knowing. They emphasized that reality is understood through embodied experience. The 
researcher therefore, used descriptive phenomenological design in order to present the experiences 
of amenorrhea following use of Depo-Provera as lived by women themselves.  
 
3.3 SETTING OF THE RESEARCH STUDY 
 Polit and Beck (2012) indicated that a setting refers to a specific place where data collection takes 
place. The setting for this research study was Chitipa District Hospital in northern Malawi. The 
district hospital is served by 8 health centers, and 73 health posts. The most widely spoken 
languages in the district are Tumbuka and Lambya despite the district having several other 
languages. The setting was purposefully selected because it has the largest family planning clinic 
that serves more women of child bearing age than any other health care facility in the district. 
There are a number of family planning methods offered at the clinic, such as implants, injectable 
contraceptives, oral pills, male and female condoms as well as IUDs. The setting registers more 
women who choose Depo-Provera as their method of choice than other contraceptive methods 
(See Table 1 below). The clinic operates on a daily basis from Monday through Friday and 
midwives are the major family planning providers at the clinic.  
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Table 1: Percentage of women of child-bearing age (WCBA) served by the respective health care 
facilities, and WCBA who utilized Depo-Provera in the 2012/2013 fiscal year (July 2012-June 
2013) at Chitipa District Hospital 
 
 
No. 
 
 
Health Care Facility in the District 
Percentage of 
WCBA served by 
the facility 
Percentage of 
WCBA who utilized 
Depo-Provera 
1 Chambo health center 7.5% (3,451) 15% (505) 
2 Chitipa Hospital 24.9% (11,503) 52% (5,940) 
3 Ifumbo Health center 3.6% (1,702) 25% (427) 
4 Kameme Health center 11.1% (5,108) 24% (1,207) 
5 Kapenda Health Center 9.8% (4,509) 10% (898) 
6 Kaseye Mission Hospital* 7.8% (3,589) - 
7 Misuku Health Center 13.4% (6,166) 9% (551) 
8 Nthalire Health Center 15.4% (7,086) 6% (460) 
9 Wenya Health Center 6.3% (2,899) 14% (417) 
10 District 46,014 23% (10,405) 
* A mission hospital which does not provide any of the modern contraceptives hence does not have data for women utilizing 
Depo-Provera. Source: Annual Family Planning Data July 2012-June 2013, Chitipa District Hospital. 
 
3.4 POPULATION 
Research population refers to a well-defined set that has certain special characteristics (LoBiondo-
Wood & Haber, 2010). The population for this study included all women of child bearing age, who 
were using Depo-Provera and attending family planning services at Chitipa District Hospital. The 
researcher purposefully selected since they may be experiencing the phenomenon (amenorrhea) 
he was investigating. 
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3.5 SAMPLING AND SAMPLING APPROACH 
Sampling means the process of selecting a sample from a population in order to obtain information 
regarding a phenomenon in a way that represents the population of interest (Brink & Brink,  2012). 
Purposive sampling, a non-probability sampling method, was used to select participants for this 
study (De Vos, 2011). According to Russell Bernard (2002), selecting a purposive sample is 
fundamental to the quality of data collected in a study, hence reliability and competence of the 
respondent has to be highlighted. According to Englander (2012), the investigator has a general 
idea of the expected parameters of the phenomenon and an interest in the phenomenon; however, 
the data collected may transcend what the investigator feels he/she knows about the phenomenon. 
Therefore, in selecting participants for phenomenological research, the participants included in the 
study should be those that have had or are having the experience. In purposive sampling, also 
called judgmental sampling, participants are selected because they possess knowledge of the 
phenomenon of interest (Clifford, 1997). The researcher therefore, needed to suspend 
predetermined assumptions in order to discover the real meaning of the phenomenon under 
investigation (Englander, 2012). The researcher sought to explore women’s experiences of 
amenorrhea following use of Depo-Provera, so as to understand the meaning attached to the 
phenomenon (amenorrhea). The researcher was aware that his own experiences of providing 
family planning methods including Depo-Provera injection to women may affect the findings of 
the study. It was for this reason that the researcher maintained his distance and prevented himself 
from taking part by allowing the participants to freely share their own experiences of amenorrhea, 
in detail and bracketing his own feelings. 
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3.5.1 INCLUSION SAMPLING CRITERIA  
Inclusion sampling criteria are the attributes that a participant must possess so that he/she can be 
included in the sample of a research study (Burns, Grove, & Gray, 2013). The inclusion criteria 
for the study included:  
 Women who had used Depo-Provera for a year or more and were experiencing amenorrhea 
following its use.  
 Women who were willing to participate and share their experiences in the study. 
3.5.2 EXCLUSION SAMPLING CRITERIA 
Burns et al. (2013) defines exclusion sampling criteria as the attributes that enables a participant 
not to be included in a sample for a research study. The exclusion criteria for the study included: 
 Women who were using Depo-Provera but were not experiencing amenorrhea. These 
would not have provided rich information that the researcher was looking for since they 
did not experience the phenomena. 
 Women who had used Depo-Provera for less than a year. These were excluded because in 
Malawi 40% of women report experiencing amenorrhea after using Depo-Provera for a 
year-long period (Sangala, 2014).  
 Women who had used Depo-Provera for a year or more and were experiencing amenorrhea 
following its use but were not willing to participate and share their experiences in the study.  
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3.6 SAMPLE SIZE FOR THE STUDY 
In a phenomenological study, the researcher seeks to be familiar with the content of the experience, 
which is often done in depth, to look for the meaning of a phenomenon and not how many people 
have experienced the phenomenon (Englander, 2012). According to Smythe (2011), the number 
of participants in a phenomenological inquiry is dependent upon the time available to undertake 
the study. She explains that in her experience, a Masters research (one year, full time), five to eight 
participants are likely to yield sufficient data. In this study, six women were interviewed. Some 
researchers such as Creswell indicate that the number of participants is based on data saturation, 
which is a point at which no new information is obtained (Creswell, 2007). However, the number 
of participants in the study was not determined by data saturation since each participant narrated 
her own story (Hein & Austin, 2001). 
 
3.7 DATA COLLECTION PROCESS 
Data collection commenced soon after ethical approval from the Senate Research committee of 
University of the Western Cape (UWC) (See Appendix F), and Malawi National Health Sciences 
Research Committee (NHSRC) (See Appendix H). Specifically, data collection was conducted 
between 5th and 16th October 2015. Since interviews help to draw a clear picture of the experiences 
of a phenomenon, from the participant point of view, and lead to understanding of shared meaning 
(Sorrell & Redmond, 1995); individual in-depth interviews were used to collect data. The 
researcher, with the help of the clinic in-charge, looked for women who had used Depo-Provera 
for a year or more by checking their health passports. The researcher then asked the women one 
by one while in the consultation room if they were experiencing or have experienced amenorrhea 
following Depo-Provera use. Those that accepted to have experienced or experiencing amenorrhea 
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were asked to indicate if they could participate in the study, and those that accepted to participate 
in the study were given an information sheet (See Appendix A). Women were told to read and 
understand the information so that they understand and make an informed choice of whether to 
take part in the study or not. For women who were willing to participate, consent forms (See 
Appendix C) were given to them to read and sign. The researcher got contact information from the 
willing participants. Each participant was given a chance to choose her convenient location, date 
and time of interview within the period of conducting the study. Participants were contacted using 
their contact information in order to locate them and conduct interviews. One-on-one, in-depth 
interviews were conducted by the researcher in Tumbuka language. Permission from participants 
was sought in order to conduct and audio-record the interviews. Most phenomenological studies 
are recorded to offer a rich source of data that can be analyzed after the interview (Mapp, 2008). 
Duration of each interview was about 40-45 minutes. Field notes were recorded by the researcher 
during each individual interview to take note of all the non-verbal behavior of the participants. 
During data collection researcher bracketed his previous experiences of working in a family 
planning clinic, as well as being a Malawian. This avoided the researcher contaminating women’s 
experiences of amenorrhea with his own experiences. According to Chan et al. (2013), bracketing 
is a methodological device of phenomenological inquiry that demands deliberate setting aside 
one’s own belief about phenomenon under study or what one already knows about the 
phenomenon prior to and throughout the investigation. For the purpose of describing the 
participants, demographic data were collected at the end of each interview, and this was not audio-
recorded.  
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3.7.1 DATA COLLECTION INSTRUMENT 
In-depth interviews were used to gather data from each participant. According to Goyal (2010), an 
in-depth interview is an unstructured interview aimed at seeking opinions of participants on one-
to-one basis. Goyal (2010) continues to state that such an interview is helpful when investigating 
sensitive topics such as menstruation, hence the use of in-depth interview as the main data 
collection instrument for this study. The major aim of using the phenomenological approach during 
the interviews is to gain a deeper understanding of the nature, or meaning of everyday experiences 
(Ahern, 1999). One general question was asked: “Can you please tell me about your experiences 
of having amenorrhea following the use of Depo-Provera as a contraceptive method?” (See 
Appendix E). This was then followed by probes and prompts such as: is there anything else to add? 
Please explain further and what do you mean by that? This was done to elicit more information on 
the phenomenon being investigated.  
 
3.8 DATA ANALYSIS 
According to Corbin and Strauss (2014:1) “Qualitative data analysis is a process of examining and 
interpreting data in order to elicit meaning, gain understanding, and develop empirical 
knowledge”. Goyal (2010), states that phenomenological data analysis emphasizes eccentric 
meaning to individuals and not shared constructions. Data analysis was done manually, alongside 
data collection. The researcher used Colaizzi’s method (as cited in Shosha, 2012) of analyzing 
descriptive phenomenological data.  
According to Shosha (2012), this method of data analysis has the following seven steps:  
 Each transcript is read and re-read in order to obtain a general idea about the whole content.  
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 Significant statements that pertain to the phenomenon under study are extracted from each 
transcript. The statements are recorded on a separate sheet; noting their pages and lines 
numbers.  
 Meanings are formulated from the significant statements.   
 The formulated meanings are sorted into categories, sub-themes, and main themes.  
 The findings of the study are integrated into a complete description of the phenomenon 
under study.  
 The fundamental structure of the phenomenon is described.  
 Finally, validation of the findings is sought from the research participants to compare the 
researcher's descriptive results with their experiences. 
In the case of this study, recorded data were transcribed verbatim. The researcher then listened to 
the tape recordings again to verify the accuracy of transcripts and make necessary changes. Every 
participant’s transcripts were read and re-read to gain a sense of the whole content, and the 
participant’s experiences were noted. Any thoughts, ideas and feelings that arose because of the 
researcher’s previous work with family planning clients were recorded in the bracketing diary. 
This assisted the researcher to explore the phenomenon as it was experienced by the women 
themselves. Significant statements and phrases regarding women’s experiences of amenorrhea 
were identified and extracted, and written on a separate sheet; noting their line and page numbers. 
Meanings were formulated from significant statements. Each underlying meaning was coded in 
each category as they reflected the main theme. Meanings were formulated into categories that 
reflected a unique structure of sub-themes. All emergent themes were defined into an exhaustive 
description. These steps were verified by an independent researcher and an agreement was reached 
based on themes and categories. This helped to determine clearly the processes that led to the 
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conclusion. Below is a table showing a selected example of significant statements under each of 
the five themes. For a step-by-step process of data analysis see Appendix G.  
Table 2: Selected example of significant statements under each theme 
Significant statement Theme  
“I did not have peace due to this cessation of 
menses….. I just thought that I am pregnant”. (Part. 01) 
Lack of knowledge on cause of 
amenorrhea 
“Stopping to menstruate was a problem to me,…..a big 
problem for that matter since what I know is that when 
one is pregnant it is the time she stops menstruating”. 
(Part. 03) 
Fear of pregnancy by Depo-Provera 
users 
“……..and that the bad blood that is supposed to be 
released during menstruation is retained inside the 
body, and which makes a woman stop child bearing”. 
(Part. 02) 
Failure by midwives to dispel rumors, 
beliefs and misconceptions associated 
with amenorrhea resulting from Depo-
Provera use. 
“Since such information is not shared to us by health 
workers I thought they do it deliberately fearing that if 
they tell us about the side effects of these family 
planning methods, most women would stop using 
them”. (Part. 02) 
Lack of proper counseling on 
amenorrhea resulting from Depo-
Provera use 
“It seems they have methods in mind that they want us 
to get without our informed consent”. (Part. 01) 
Control over contraceptive decision 
making by midwives. 
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“I did not worry much because I was already told at the 
hospital that this is what I may be experiencing if using 
the injection of Depo-Provera, and I was pretty sure 
that I am not pregnant as the nurse explained to me”. 
(Part. 04) 
Amenorrhea not perceived as a 
problem when midwives provide 
adequate information 
 
3.9 TRUSTWORTHINESS OF THE STUDY 
Qualitative research should demonstrate trustworthiness in providing rigor and strength to the 
study validity and reliability in all stages including data collection, data analysis and descriptions 
(Speziale, Streubert, Carpenter, & Rinaldi, 2007). According to Brink & Brink (2012), 
trustworthiness refers to a way of guaranteeing data quality or rigor in qualitative research. 
Trustworthiness approaches; credibility, dependability, confirmability, and transferability were 
undertaken throughout the study process (Shosha, 2012).  
 
3.9.1 CREDIBILITY 
Credibility refers to faithfulness in the way a phenomenon under study is described (Koch & 
Harrington, 1998). It ensures that there is consistency between participants’ views and researcher’s 
interpretation of their views (Ryan, Coughlan, & Cronin, 2007). Credibility in this study was 
achieved by returning to the women soon after data collection process and they were made to read 
the transcripts of the dialogues in which they took part. The researcher read the transcripts to 
participants who were unable to read. This allowed participants to verify if their words confirm 
what they really wanted to say (Shenton, 2004). Researcher included only women who accepted 
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and were willing to take part in the study as thus ensured their honesty in the information shared 
in the study. 
3.9.2 DEPENDABILITY 
 Dependability involves giving the reader enough information so that he or she can decide how 
dependable both the study and investigator are (Ryan et al., 2007). Dependability was enhanced 
by peer examination and discussing the research process with research supervisor who is 
conversant with qualitative research.  
3.9.3 CONFIRMABILITY 
Confirmability requires that an investigator shows how he has arrived at his conclusions and 
interpretations, and is concerned with establishing that results of the study are really coming from 
data given by participants (Tobin & Begley, 2004). Confirmability was achieved by developing an 
audit trail, which is a documentation of the entire research process. This allowed an independent 
co-coder to audit the process, and later on the themes of both were compared. They then agreed 
on which themes really described what respondents’ experiences were. The research supervisor 
was also involved in the whole process of research starting from raw data to the final report. The 
procedure on how themes were arrived at during the analysis process has been included (see 
Appendix J).  
3.9.4 TRANSFERABILITY 
According to Ryan et al. (2007) transferability refers to whether study findings can be applied 
outside the context where the study was undertaken. The researcher has provided rich contextual 
information for the study setting (See section 1.7) so that readers can be able to view the findings 
to be meaningful and applicable as regards their own experiences.   
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3.10 ETHICAL CONSIDERATIONS 
According to Craven, Hirnle, and Jensen (1992) ethics refers to a branch of philosophy that deals 
with standards of conduct and moral judgment. The need to provide evidence-based practice in 
nursing profession is of vital importance, however when people are used as study participants, care 
must be taken to ensure that their rights are well protected (Polit & Beck, 2008). Ethics clearance 
was obtained from the UWC’s Senate Research Committee (See Appendix H). Permission to 
undertake the study in Malawi was sought from NHSRC (See Appendix I), and permission to 
conduct study at the hospital was obtained from the District Health Officer at Chitipa District 
Hospital (See Appendix J).  
3.10.1 INFORMED CONSENT 
All participants were autonomous thus they had a right to self-determination (Brink & Brink, 
2012). Participation was voluntary, and participants were informed of their freedom to withdraw 
at any time during the study and were assured that no punitive measures were to follow their 
withdrawal. The participating women signed an individual written consent (See Appendix C) 
indicating acceptance to take part in the study. A finger print mark was obtained from women (2 
participants) who were unable to write. According to Fouka and Mantzorou (2011) informed 
consent is a means where by a client’s right to autonomy is protected. Participant information 
sheets (See Appendix A) detailing study purpose, risks and benefits, freedom to withdraw from 
participation and emphasis on the protection of confidentiality were provided to participants. 
Informed consent and participant information sheet were translated in Tumbuka language to assist 
women understand purpose of study and their role as participants. 
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3.10.2 CONFIDENTIALITY AND ANONYMITY 
Participants were guaranteed confidentiality with regard to private and personal information by 
not using their names. Recorded data and field notes were coded to ensure anonymity of data so 
that they could not be traced to the names of participants. Participants were assured that recorded 
data will be kept in a lockable place to which only the researcher and supervisors had access to. 
The In-depth interviews were conducted in participants’ homes, to ensure privacy and 
confidentiality. All the interviews were conducted in quiet places and in the presence of spouses, 
except for one respondent who requested to be interviewed at the clinic. She was using Depo-
Provera without the knowledge of her husband. This particular interview was conducted in a quiet 
office that was provided by the clinic in-charge.  
3.10.3 PROTECTION FROM HARM 
There was no risk for the participants who took part in this study. However, the researcher had 
planned to refer any participant who became distressed in the course of the interviews, to a 
psychiatric nurse for counseling, and also to stop the interview process so that it could be continued 
at another time when the concerned participant would be comfortable and willing to continue with 
the interview. 
 
3.11 LIMITATIONS OF THE RESEARCH STUDY 
Being phenomenological, the results of the study are context-specific to the population that was 
under study, thus the findings cannot be generalized. They are limited to six women experiencing 
amenorrhea, and attending family planning services at Chitipa District Hospital in Malawi. 
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However, the findings being context-specific, does not mean that they cannot be applicable to 
other settings.  
 
3.12 DISSEMINATION OF STUDY FINDINGS 
The findings of the study will be published, with the guidance of the research supervisor after 
completion of the project. The researcher will present study findings to health workers, mainly 
midwives at one of the morning conferences at Chitipa District Hospital and during one of the 
training workshops for health service providers. A copy of the research report will be made 
available to Chitipa District Hospital, Malawi Ministry of Health as well as UWC Library. 
 
3.13 CONCLUSION 
In this chapter the researcher outlined and discussed the methodology and methods that were 
applied to the research study. It also looked at the limitations to the study as well as plan for 
dissemination of study findings. The next chapter focuses on the presentation of study findings.  
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CHAPTER 4 
FINDINGS OF THE STUDY 
4.0 INTRODUCTION 
This chapter presents socio-demographic characteristics of the participants and the findings of the 
study. From the data analysis themes and sub-themes emerged, and are thus presented.  
 
4.1 SOCIO-DEMOGRAPHIC CHARACTERISTICS OF PARTICIPANTS 
The age of the participants ranged from 21 to 33 years, and all of them were married except one 
who was divorced. Out of the six respondents, five of them had one child each at the time of 
conducting the interview while one of them, who happens to be the oldest of all five participants 
had five children. Two of the participants had reached primary school, another two were secondary 
school drop outs while one had been to tertiary academic institution. All the five participants 
indicated to be Christians.  
 
4.2 THEMES AND SUB-THEMES 
Five themes emerged from data after analysis, and these themes led to the emergence of the 
fundamental structure. Three themes have sub-themes while two of the five themes do not have 
sub-themes. Both the themes and sub-themes describe the women’s experiences of amenorrhea 
following Depo-Provera use. The following are the themes and their sub-themes:  
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Table 3: Themes and sub-themes 
Theme Sub-theme 
Lack of knowledge on cause of amenorrhea Worry over Depo-Provera induced 
amenorrhea 
Discontinuing Depo-Provera due to 
amenorrhea 
Fear of pregnancy   
Misconceptions associated with Depo-Provera 
induced amenorrhea 
Fear of infertility 
Lack of proper counseling on amenorrhea 
resulting from Depo-Provera use 
Women’s preference for information 
Control over contraceptive decision making by 
midwives 
Amenorrhea not perceived as a problem when 
midwives provide adequate information 
 
 
4.3 THEME ONE: LACK OF KNOWLEDGE ON CAUSE OF AMENORRHEA 
Four of the participants stated that they did not understand the cause of cessation of menses which 
they were experiencing. This was expressed by participants 02 and 06 as they reported to have 
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become worried after noticing that their menses had ceased. This led to the sub-theme ‘worry over 
Depo-Provera induced amenorrhea’. 
4.3.1 WORRY OVER DEPO-PROVERA INDUCED AMENORRHEA 
Participants reported that they developed cessation of menses as a result of using Depo-Provera. 
One participant expressed worry after noticing that her menses had ceased. She stated: 
“In using this method I discovered that I started experiencing cessation menses. Knowing that this 
problem started after I started using Depo-Provera I was very much worried” (looking very 
concerned). Part. 01 
Another participant stated that she was worried when she discovered that her menses had ceased 
while she was using Depo-Provera. For instance participant 06 reported that: 
“I was menstruating before using this method so this was really a worry for me…….”Part. 06 
One participant reported that she was devastated after noticing that her menstruation had ceased. 
She stated: 
“I started using Depo-Provera in the year 2013, and soon after getting two injections of Depo-
Provera I developed amenorrhea, and due to this I was so much devastated that I did not have 
peace in my mind” (speaks with loud voice). Part. 02 
One participant reported that she did not find cessation of menses as a problem as she had already 
been informed of what she might be experiencing if using Depo-Provera. She was not worried of 
her state of ceased menses. She stated: 
“I did not worry much because I was already told at the hospital what I may be experiencing if 
using the injection of Depo-Provera…….” (Smiling). Part. 04 
 
 
 
 
37 
 
One participant who had expressed worry over amenorrhea reported that she wanted to stop using 
Depo-Provera as her preferred method of contraception, and this led to the emerging sub-theme 
‘discontinuing Depo-Provera due to amenorrhea’. 
4.3.2 DISCONTINUING DEPO-PROVERA DUE TO AMENORRHEA 
One participant stated that she wanted to stop using Depo-Provera mainly because she was not 
having her menses anymore. She stated:  
“I wanted to stop using Depo-Provera because of cessation of my menses since I surely knew that 
it was coming due to the injection”. (Frowns her face, while talking with her hands). Part. 06 
Lack of knowledge on the cause of amenorrhea was found to be the major problem on the part of 
participants, as five of them reported that their ceased menses meant that they were pregnant. This 
led the researcher to come up with the second theme ‘fear of pregnancy by Depo-Provera users’. 
The participants linked their cessation of menses to pregnancy. 
 
4.4 THEME TWO: FEAR OF PREGNANCY  
This theme entails that participants regarded their cessation of menses as a sign of pregnancy while 
using Depo-Provera as a contraceptive method. Four of the six participants had the belief that they 
were pregnant in view of their ceased menstruation. One participant reported that she was afraid 
of having another pregnancy, which she considered as unplanned as it will have come at a time 
when they were not expecting it. The participant also stated that as a result of this she went back 
to the hospital so that she could be tested to confirm if she was pregnant. She said:  
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“To my knowledge, when a woman or girl stops menstruating it is a sign that she is pregnant. I 
was afraid because I believed that I was pregnant which was unplanned. Since I was not told at 
the time of starting the method, I went back to the hospital so that I can be tested to know if I am 
pregnant or not, also that I should ask what I am experiencing because it was strange to me”. Part. 
02 
And when this participant went to hospital, she reported that she could not believe what the health 
worker had told her: that she was pregnant. She stated:  
“I was surprised when I was told by the health worker that I am not pregnant but that it is the 
injection that is making me stop menstruating. I did not believe since the doctor that initiated me 
on the method did not tell me about this effect of having ceased menstruation…..” Part. 02 
 
Another participant stated that she thought she was pregnant because she was of the understanding 
that cessation of menses is always linked to pregnancy. She had this to say: 
“………. since what I know is that when one is pregnant it is the time she stops menstruating”. 
Part. 03 
One participant reported that she did not have peace because she thought that she was pregnant 
when she noticed that her menses had ceased. She stated: 
“I did not have peace due to this cessation of menses….. I just thought that I am pregnant…..” 
Part. 01 
Another participant also reported that she returned back to hospital with her husband so that she 
could be tested as a confirmation that she was not pregnant. Even when they were told that 
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cessation of her menses was not an indication of pregnancy, the participant stated that she did not 
believe this and opted to go to private clinic for testing to confirm if really she was not pregnant.  
She said:  
“…together with my husband I went to the hospital so that I can be tested to confirm if I am 
pregnant or not. “Even after coming from the hospital we were still not convinced (speaks with 
her hands on her cheeks), my husband too did not believe what the nurse told us. The next morning 
my husband gave me money so that I should go to Banja La Mtsogolo to be tested for pregnancy.” 
Part. 05 
The fear of pregnancy was necessitated by rumors, beliefs and myths that participants had heard 
from friends and other women. Four participants reported negative stories associated with 
amenorrhea when a woman is using Depo-Provera. This led to the third theme, which is 
misconceptions associated with Depo-Provera induced amenorrhea. 
4.5 THEME THREE: MISCONCEPTIONS ASSOCIATED WITH DEPO-PROVERA 
INDUCED AMENORRHEA 
Four of the participants reported rumors and beliefs associated with Depo-Provera induced 
amenorrhea. They stated that when a woman is experiencing amenorrhea while using Depo-
Provera it may lead to the woman not being able to conceive. This led to a sub-theme of fear of 
infertility.   
4.5.1 FEAR OF INFERTILITY 
The four participants shared their unconfirmed rumors and beliefs associated with amenorrhea 
resulting from the use of Depo-Provera as a contraceptive method. All of the rumors, beliefs and 
misconceptions pointed towards infertility.  
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One participant stated that she had been informed by her friends that when a woman is no longer 
having her menses it means the injection is forming particles in the womb and that bad blood that 
is expected to be got rid of when a woman is menstruating collects inside the body.  She continued 
to report that this results into women being unable to bear children anymore. She said:  
“I had already been informed by other people that if one stops menstruating while using Depo-
Provera injection it means the drug forms some solid particles inside the womb, and that the bad 
blood that is supposed to be released during menstruation is retained inside the body, and which 
makes a woman stop child bearing…….” Part. 02 
Another participant stated that she had heard from her friends that using Depo-Provera leads to 
women not able to get pregnant again. She continued to report that the injection of Depo-Provera 
leads to growth of tumors in the womb, which leads to infertility. She indicated that loss of menses 
means failure by the body to get rid of contaminated blood. She said: 
“I just thought I have developed a big problem in my life. I even started thinking as true what other 
women have been saying that when one is using Depo-Provera she stops getting pregnant 
again…….and some say the injection causes tumors in the womb that make a woman stop being 
fertile again. In addition, when you are not menstruating it means the body is unable to get rid of 
contaminated blood”. Part. 03 
Two participants reported that if a woman stops menstruating she is no longer considered to be a 
woman. One participant stated that a real woman is expected to have her menses normally. She 
said: 
“In addition, for people to call you a woman you are supposed to be having your menses, some 
people even scorn at you that you are not a woman if you don’t menstruate”. Part. 02 
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Another participant also stated that fellow women do not consider a woman with ceased menses 
as a woman. She said: 
“…….and also that your fellow women stop to regard you as a real woman”. Part. 03 
The participants reported such rumors and beliefs due to lack of information on Depo-Provera 
induced amenorrhea. Five participants stated that they are not counselled appropriately when they 
are being initiated on Depo-Provera injection as a contraceptive method. This led the researcher to 
the fourth theme ‘lack of proper counseling on amenorrhea resulting from Depo-Provera use. 
 
4.6 THEME FOUR: LACK OF PROPER COUNSELING ON AMENORRHEA 
RESULTING FROM DEPO-PROVERA USE  
Five of the six participants stated that midwives did not provide them with appropriate information 
on amenorrhea when they were given Depo-Provera injection. The participants indicated that they 
needed proper information so that they know what happens to them in the course of using Depo-
Provera. In addition two participants stated that they were coerced to accept Depo-Provera 
contraceptive method. The participants’ desire for information and lack of informed consent 
pointed to two sub-themes; women’s preference for information on amenorrhea and control over 
contraceptive decision making by midwives. 
4.6.1 WOMEN’S PREFERENCE FOR INFORMATION 
Five participants were concerned that midwives did not provide them with proper information 
concerning side effects of Depo-Provera, mainly amenorrhea which was a concern to them as 
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reported in their interviews. One participant stated that midwives do not want to share such 
information for fear that the women would stop using the method. She stated: 
“Since such information is not shared to us by health workers, I thought they do it deliberately 
fearing that if they tell us about the side effects of these family planning methods, most women 
would stop using them.” Part. 02 
There was one participant who reported that midwives hide information to them since they know 
that Depo-Provera is harmful to their bodies. She narrated: 
“……..because if there is no harm that they can do to our bodies these health workers would not 
be hiding from us such information.” Part. 03 
Three participants shared their experience while at the hospital, and stated that they were initiated 
on Depo-Provera without any counseling at all. One participant explained that she was given Depo-
Provera but she was not told what she could anticipate in terms of side effects while using the 
method. She explained:  
“…….we got the injection of which we were not told on how it functions, and what we should 
anticipate while using the method.” Part. 01 
Another participant shared a similar concern by explaining that at the hospital they are not told 
what effects would come after using Depo-Provera. She said: 
“Again at the hospital they just gave us the injection without explaining what would come after 
using the method.” Part. 06 
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One participant stated that the doctor who initiated her on the method did not counsel her on the 
possibility of experiencing amenorrhea as a result of Depo-Provera use, and due to this she was 
worried because she had been having her menses normally before getting the injection. She said: 
“At first I was surprised because to me it was my first time by then to use this method of family 
planning… the major problem was that when I was starting the method the doctor did not tell or 
explain to me anything, so when cessation of menses came I was worried since beginning my 
youthful days as a girl I have been menstruating, except when I am pregnant”. Part. 03 
One participant reported the need for midwives to share appropriate information concerning Depo-
Provera considering that there are many negative stories surrounding its use. And she also 
expressed worry that despite Depo-Provera being utilized by most women, useful information 
pertaining to the method is not shared to them. She explained: 
“It is important that health workers should tell us the truth about methods of family planning, 
especially the injection because we hear a lot of negative stories from our friends. Even at the 
hospital we are not assisted since they hide useful information concerning family planning methods 
most especially Depo-Provera injection since it is the method most of us women like.” Part. 05 
Participants stated that they needed proper information so that they know what side effects could 
be anticipated in their use of Depo-Provera, mainly amenorrhea. Such information could help them 
make informed choice on contraceptive methods as stated by two participants, midwives had 
control over their decision making; they were made to accept Depo-Provera. This led to another 
sub-theme namely ‘control over contraceptive decision making by midwives. 
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4.6.2 CONTROL OVER CONTRACEPTIVE DECISION MAKING BY MIDWIVES 
Two participants reported that midwives played a big role in choosing for them what contraceptive 
method they need to use. One participant specifically indicated that probably the midwives already 
have methods of family planning that they would want the women to use. She stated: 
“It seems they themselves have methods in mind that they want us to get without our informed 
consent”. Part 06  
One woman stated that she accepted Depo-Provera because the midwife was mentioning it several 
times. She explained: 
“I got the injection because the nurse was mentioning it several times at the clinic that it was the 
only one available…..” Part. 01 
Despite five of the six participants narrating that they did not receive appropriate information on 
Depo-Provera induced amenorrhea, there was one participant who stated that she had received 
counseling on the method, and that she was told the possibility of developing cessation of menses 
in her use of Depo-Provera. This therefore led to the fifth and final theme ‘amenorrhea not 
perceived as a problem when adequate information is provided’.  
 
4.7 THEME FIVE: AMENORRHEA NOT PERCEIVED AS A PROBLEM WHEN 
ADEQUATE INFORMATION IS PROVIDED BY MIDWIVES 
Despite five participants indicating that information on Depo-Provera induced amenorrhea is not 
shared by midwives, one participant narrated a different experience. She stated that she was 
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counseled that amenorrhea while using Depo-Provera does not mean that a woman is pregnant. 
She stated that she was not worried when she noticed that her menses had ceased. She stated: 
“The nurse explained to me how the injection works by saying some women may experience heavy 
bleeding, some may have spotting while some do stop having menses completely. I was also told 
that if I stop menstruating it means that there is no problem and that women should not be worried 
about this…… it does not mean that a woman is pregnant. I did not worry much because I was 
already told at the hospital that this is what I may be experiencing if using the injection of Depo-
Provera, and I was pretty sure that I am not pregnant as the nurse explained to me”. Part. 04 
The participant stated that she did not even consider amenorrhea as a problem since she was 
already told about the effect at the hospital. She stated: 
“I did not regard amenorrhea as a problem because I was told the effects at the hospital”. Part. 
04 
The participants expressed fear when they noticed that their menses have ceased. This was 
attributed mainly due to lack of knowledge on the cause of amenorrhea while they were using 
Depo-Provera as a contraceptive method. The fear was made clear by the participants when they 
stated that they were afraid of pregnancy, and that they were afraid of becoming infertile due to 
their ceased menses. Others stated that they were afraid by expressing worry over the development 
of cessation of menses.  
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4.8 THE FUNDAMENTAL STRUCTURE OF THE PHENOMENON 
A fundamental structure of a particular phenomenon under investigation is the articulation of the 
moment in the mental picture of the investigator and comprehension based on accepted 
presuppositions and situational circumstances (Edward, 2007). In this context, the researcher 
integrated the findings of the data analysis into a fundamental structure of the phenomenon that 
was being studied; women’s experiences of amenorrhea following Depo-Provera use. A 
fundamental structure is an essence of the experiential phenomenon as it is revealed by explication 
through a rigorous analysis of the exhaustive description of the phenomenon.  In this study, the 
fundamental structure: “Fear” was generated through adherence to Colaizzi’s process (as cited in 
Shosha, 2012) of phenomenological data analysis. 
4.8.1 FEAR 
 Fears about the side effects from the use of Depo-Provera are well documented barriers to use of 
the method. Many of these fears are due to misinformation, however, some of these fears reflect 
real experiences (Diamond-Smith et al., 2011). These fears cause a change in behavior and the 
response to fear may lead to avoiding the threat, which in this case is Depo-Provera induced 
amenorrhea which comes as a side effect. Darroch, Sedgh and Ball (2011) indicated that despite 
that much of the literature assumes that financial cost is the core factor in preventing Depo-Provera 
use, surveys from around the world suggest that fear of side effects of Depo-Provera are more 
influential in contraceptive decision making (Darroch et al., 2011). Participants in this study 
perceived their experiences of amenorrhea as a threat to fulfilling their reproductive role in their 
families pertaining to the high significance value fertility is held by communities. Firstly, they 
were afraid of their state of cessation of menses, which was attributed to lack of accurate 
contraceptive information sources, mainly on the cause of amenorrhea. Secondly, participants 
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were afraid of infertility as expressed in the reported beliefs and misconceptions associated with 
amenorrhea such as the injection leading to formation of solid particles in the womb, and failure 
to get rid of contaminated blood from the body. Thirdly, participants were afraid of unplanned 
pregnancy as they were misinformed by peers that amenorrhea was a clear indication of pregnancy. 
Lack of appropriate contraceptive information on side effects such as amenorrhea was a core driver 
of fears and misconceptions which often led to discontinuation of the method. Family planning 
counseling should not only aim at providing accurate contraceptive information but should be 
tailored to address fears, negative beliefs, misconceptions and side effects. Fostering patient-
midwife interaction enhances prolonged contraceptive use (Alaii, Nanda, & Njeru, 2012). Patients 
need to be comfortable to ask family planning providers about negative rumors, beliefs, 
misconception and fears, and be able to report side effects as this will make them more likely to 
discuss with providers on options for contraceptive switching if needed, rather than discontinuing 
Depo-Provera (Alaii et al., 2012). 
 
4.9 CONCLUSION 
This chapter presented the study findings. It mainly presented a detailed outline of the five themes 
that emerged from the analyzed data. Direct quotations from participant’s interviews were included 
to support their own expression of the experiences of amenorrhea following Depo-Provera use as 
a contraceptive method. The next chapter will focus on the discussion of the findings, in relation 
to relevant literature.  
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CHAPTER 5 
DISCUSSION OF FINDINGS 
5.0 INTRODUCTION 
This chapter presents the discussion of findings in relation to relevant literature. The discussion is 
mainly on the five themes and sub-themes that emerged from the data after analysis. 
 
5.1 LACK OF KNOWLEDGE ON CAUSE OF AMENORRHEA 
Most of the participants showed lack of knowledge on cause of amenorrhea. This was reflected by 
the fear that they expressed upon noticing that they are no longer having their menstruation. They 
became worried as an expression of fear due to the changing menstrual pattern from normal and 
regular menses to no menstruation at all. The findings are consistent with the findings by 
Hubacher, Goco, Gonzalez, & Taylor (1999). In their study to estimate continuation rates of Depo-
Provera that was done in Bolivia in 30 government health centers. In their study, 79% of family 
planning providers were able to explain about the contraceptive effectiveness of injectable Depo-
Provera to their clients but they could not inform the women on possible menstrual side effects 
most especially amenorrhea. In the same study only less than 50% of the women were explained 
about the probability of amenorrhea while approximately 80% of the women were not told on how 
to handle side effects if they occur. 
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5.1.1 WORRY OVER DEPO-PROVERA INDUCED AMENORRHEA 
Participants became worried due to development of amenorrhea mainly because they were not told 
about what really brings about the side effect, however on their own they could suspect that it was 
the Depo-Provera contraceptive that they were using that was causing them to stop menstruating. 
In their study to find out factors affecting the intentions of men and women to use family planning 
methods, Chipeta, Chimwaza, and Kalilani-Phiri (2010) it was revealed that some of the female 
participants fail to use Depo-Provera due to fear of side effects such as amenorrhea. In agreement 
with this, Repta and Clarke (2013), in their research on Canadian women’s perception and 
experience of menstrual suppression, found out that women whose menstrual pattern was not 
suppressed by use of Depo-Provera expressed fear about the prolonged consequences of taking 
Depo-Provera such as not having menstruation anymore. To them monthly periods were 
considered to be inherently healthy and was a sign of good health, and was therefore referred to as 
an important barometer of health. 
5.1.2 DISCONTINUING DEPO-PROVERA DUE TO AMENORRHEA 
When the possibility of amenorrhea as a side effect is not shared to clients by midwives who are 
the major providers of family planning services in Malawi, women are bound to discontinue use 
of Depo-Provera. This is because if they discover on their own that their loss of menstruation 
started after using Depo-Provera they might not return to hospital or clinic for the next injection. 
In this study one participant expressed the possibility of discontinuing use of Depo-Provera 
because she had discovered that she developed amenorrhea, a side effect which was not shared by 
the providers at the time she was being initiated on the method. This is in consistent with what 
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Hubacher et al. (2009) found in their study in which women who were offered information on 
Depo-Provera efficacy, side effects and amenorrhea were more likely to continue using the 
injectable contraceptive than those women who were not offered such information. In the same 
vein, participants who were explained about the possibility of amenorrhea became 2.5 times more 
likely to continue using Depo-Provera than those women who did not receive this type of 
information. Women who had a feeling that being able to menstruate is a requisite for sustaining 
optimal health were more likely to discontinue use of Depo-Provera than those women who did 
not express such sentiments (Hubacher et al., 2009). Hubacher et al. (1999) explained that despite 
that there will always be women who discontinue use of Depo-Provera; midwives would increase 
the length of time that women would use the method. They concluded that midwives who only 
focus on positive qualities of Depo-Provera may be unwittingly fostering short term use of the 
injectable contraceptive. They also recommended that midwives need to encourage women to go 
back to the hospital if they experience amenorrhea which they might think will bring harm on their 
bodies (Hubacher et al., 1999). 
In a study (N= 350) to determine the effect of counseling on discontinuation of Depo-Provera 
given as a contraceptive in which amenorrhea was the main side effect, De Cetina, Canto, and 
Luna (2001) indicated that most participants who were offered structured counseling opted to 
continue using Depo-Provera than those that did not receive counseling regardless of the collateral 
side effects. As an overall, those women who were counselled statistically showed a significant 
discontinuance rate (P˂0.05) than those that did not receive any counseling. More women who 
were not offered counseling discontinued Depo-Provera primarily as a result of amenorrhea which 
they experienced (De Cetina et al., 2001).  
 
 
 
 
51 
 
In a qualitative study done on 42 women and 32 service providers, to explore the acceptability of 
Depo-Provera and side effects experienced by women, Hyttel, Rasanathan, Tellier, and Taremwa 
(2012) indicated that all participants (n=16) who discontinued Depo-Provera cited amenorrhea as 
the major reason while eight women explained that amenorrhea and its impact on intimate 
relationships made them to discontinue its use. Another qualitative study involving 14 Focus 
Group Discussions done in Kenya, on reasons for discontinuing Depo-Provera among users, one 
woman expressed that her concerns regarding lack of menstruation made her decide to stop using 
Depo-Provera until when her menstruation starts again (Burke & Ambasa-Shisanya, 2011). She 
was of the view that since she was not seeing any blood, probably they were being collected 
somewhere in her body because starting from the time she started using Depo-Provera she had not 
seen blood as she used to do in the past (Burke & Ambasa-Shisanya, 2011). 
In a longitudinal multi-centric research program conducted in Iran on menstrual changes (N=411), 
Sadeghi-Bazargani and Fardyazar (2006) recommended that in order to minimize women 
discontinuing use of Depo-Provera there is need that providers explain to users that amenorrhea 
caused by the injectable contraceptive is harmless, and that sometimes it may be beneficial to those 
women who are anemic. They stated that Depo-Provera users must know that the injectable 
contraceptive has a very small failure rate and cessation of menstruation after a standard Depo-
Provera injection is mostly rare to be as a result of pregnancy (Sadeghi-Bazargani & Fardyazar, 
2006). 
This indicates that amenorrhea as a side effect of Depo-Provera would contribute greatly to the 
discontinuation in use of the method by most women who consider cessation of menses as 
abnormal, which is common to most women in Africa, as well as other regions of the world. In a 
retrospective study conducted in India on perspectives and experiences of women and family 
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planning providers on Depo-Provera in India, Jejeebhoy and Zavier (2012) stated that providers 
agreed that women’s primary reason for discontinuing Depo-Provera was amenorrhea. 
 
5.2 FEAR OF PREGNANCY  
Pregnancy becomes a burden on women’s lives most especially when they did not plan for it. Most 
women interviewed in this study registered their fear of getting pregnant since they could no longer 
see their monthly periods after using Depo-Provera. The first thing they suspected was that they 
are pregnant, and this was worsened by the fact that they were not explained that Depo-Provera 
could lead to cessation of menses. According to the participants, if one stops menstruating then it 
means that she is pregnant regardless that she is using Depo-Provera. This is in agreement with 
what Cheung and Free (2005) found in their qualitative study (N=51) on factors influencing young 
women’s decision making regarding hormonal family planning methods; they found that for most 
of the women involved in the study having regular menstruation represented what was not only 
normal but also natural. For them having a regular menstruation cycle depicted a body balance and 
that it was reassuring to them since they knew that they are not pregnant. As such women did not 
like Depo-Provera and other methods that led to amenorrhea or rather methods that caused an 
unnatural state to their bodies (Cheung & Free, 2005). This is probably the reason why most of the 
participants in this study had to go back to the hospital so that they can complain about the 
amenorrhea, which to them it was a problem because they lacked information on why they were 
experiencing it. Two of these participants had to explain that they went back to hospital in order 
that they be offered a pregnancy test to confirm that they are not pregnant. Even when one of the 
participants was told at the clinic that her loss of menses was not an indication that she was 
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pregnant, she could not believe this, and decided to go a private health care facility where she paid 
just to get tested for pregnancy. 
Jejeebhoy and Zavier (2012) carried out in-depth interviews on experiences and perspectives on 
Depo-Provera to family providers. The providers explained that women were afraid of pregnancy 
when they discovered that their menstruation had ceased, and due to this they discontinued the 
method. In a qualitative study (N=14) to investigate experiences of women with Depo-Provera 
conducted by Hampton and McWatters (2003) findings suggested that there is a relation between 
characteristics of a contraceptive method such as having side effects, and characteristics of the 
user (her perception of the side effect) that usually determined the desire to continue that method. 
Women who perceived amenorrhea as harmful, unnatural and unacceptable indicated their 
unwillingness to continue using Depo-Provera. In another qualitative study (N=491) to find out 
rates of discontinuation of injectable Depo-Provera, Davidson et al. (1997) found out that the 
majority of participants cited amenorrhea as a major reason for discontinuing Depo-Provera and 
not problems faced when returning to clinic every three months for subsequent injections. Three-
quarters of the female participants cited cessation of menses, which accounted for 36% of women 
who discontinued Depo-Provera compared to other side effects that shared a 39% discontinuation 
rate (Davidson et al., 1997). 
 
5.3 MISCONCEPTIONS ASSOCIATED WITH DEPO-PROVERA INDUCED 
AMENORRHEA  
Misconceptions associated with Depo-Provera induced amenorrhea can prevent women from 
using the injectable contraceptive. In this study, women expressed their beliefs about menstruation, 
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and rumors that they had heard from friends, and which they believed to be true since they could 
not access such information from family planning providers themselves. According to Creel, Sass, 
and Yinger (2002) misconceptions associated with Depo-Provera could raise potential concerns 
for women about side effects, safety and effectiveness of various family planning methods, and 
that the presence of these beliefs and rumors highlights the significance of providing women and 
other family planning users about the pros and cons of contraceptive methods.  
Chap and Escoffier (1996) stated that all traditional societies possess naturalistic views concerning 
the functioning (growth and decay) of the body. The body is considered as a microcosm while the 
monthly periods mark the rhythms of the life cycle. They continued to explain that when the 
menstrual flow is ‘red, abundant and without odor’, it is mostly liked by women as guarantee to 
the proper functioning of the body. Abundant bleeding is linked to fertility and good health. 
Menstruation is believed to renew the old or ‘dead blood’ as new fresh blood provides strength, 
beauty and restores the health of a woman (Chap & Escoffier, 1996). De Cetina et al. (2001) found, 
in their study (N=350) on the effect of pre-treatment counseling on discontinuation of Depo-
Provera in Mexican women, that in rural areas women had the belief that amenorrhea leads to bad 
blood being deposited in the womb which later brings about a toxic effect. Hampton and 
McWatters (2003) found out that women who discontinued use of Depo-Provera as a result of 
frightening rumors from friends did not receive accurate information from providers to counteract 
misinformation. Such rumors though taken lightly by providers, they have an impact on Depo-
Provera users (Hampton & McWatters, 2003). 
5.3.1 FEAR OF INFERTILITY 
Almost all the participants interviewed were afraid of becoming infertile in their use of Depo-
Provera as a contraceptive method. Their major concern emanated from the fact that Depo-Provera 
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led to cessation of their menstruation, which they considered to come about due to its ability to 
cause tumor growth and some form of solid particles in the womb which in turn may lead to them 
becoming sterile. They considered lack of menstruation as having poor health. In consistent with 
this, in their qualitative study to understand how Cambodian women think concerning natural and 
modern contraceptive methods and the various factors influencing their option of contraceptives, 
Chap and Escoffier (1996) found out that women regarded their counterparts who were sterile as 
having poor health since they do not have monthly periods. It was also revealed that most women 
monitor the quantity, quality and regularity of their menstrual flow very carefully, and that any 
changes such as amenorrhea would raise fears and anxiety about their health. The use of Depo-
Provera raises immediate concern and suspicion and is seen as disturbing the natural harmonious 
balance (Chap & Escoffier, 1996).  
In another qualitative study by Chipeta et al. (2010) on contraceptive knowledge, beliefs and 
attitudes in rural Malawi, it was found out that women fail to use Depo-Provera due to negative 
attitudes, myths and beliefs that surround its use. Women expressed a common belief that Depo-
Provera affects male reproductive organs, leading to them being impotent (Chipeta et al., 2010). 
In a qualitative study (N=46) to explore the acceptability of Depo-Provera and side effects 
experienced by women and impact on their relationships, Hyttel et al. (2012) revealed that eight 
women were concerned that Depo-Provera will cause infertility. In addition to reduced sexual 
pleasure and availability, fear of infertility and delayed return to fertility women were also 
concerned about the stability of their relationships. Chap and Escoffier (1996) stated that women 
try to find rational explanations about amenorrhea which is one of the most frequent reported side 
effects of injectable Depo-Provera. In their study participants raised a concern that blood retained 
in their bodies will lead to an abdominal lump which will later develop into a tumor or a cancer in 
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the near future. This is also the same with what two participants in this study believed when they 
stated that amenorrhea might lead to formation of solid particles and tumor growth in the womb, 
and later cause them to become sterile. 
Do Amaral, Hardy, Hebling, and Faúndes (2005) carried out a qualitative study (N=64) on opinion 
of Brazilian women on menstruation and amenorrhea, and in their discussion on amenorrhea it was 
found out that women believed that menstrual blood is dirty and menstruation is a means to purify 
the body. They believed menstruation leads to elimination of bad blood which has a natural path 
to leave the body. They women had a question as to say ‘if it was not eliminated from the body 
using its natural path, then where would it go?’ (Do Amaral et al., 2005).  
This is in agreement with what was found in this study whereby participants also shared their belief 
that if using Depo-Provera and one has amenorrhea, it means that contaminated or bad blood is 
retained in the body. Midwives need to act on the beliefs, myths, rumors and even fears and 
anxieties that come concerning amenorrhea. They need to explain to users that amenorrhea is not 
harmful to one’s health. 
 
5.4 LACK OF PROPER COUNSELING ON AMENORRHEA RESULTING FROM 
DEPO-PROVERA USE 
Counseling is vital if women are to effectively use contraceptive methods. Proper counseling can 
lead to women use a contraceptive for a prolonged period. However, it is not usual for midwives 
to offer such type of counseling when initiating women on various family planning methods, 
including Depo-Provera. Five participants indicated that despite being initiated on injectable 
Depo-Provera midwives did not initially counsel them on the method, particularly on amenorrhea, 
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which reportedly affects most women using the method. According to Dehlendorf et al. (2014) 
qualitative research studies in the United States on women’s experiences on counseling revealed 
that users of contraceptives frequently are dissatisfied with the type of counseling they receive. 
Their concern mainly was that providers hide information on side effects (Dehlendorf et al., 2014).  
Midwives need to consider prioritizing provision of accurate information on amenorrhea to 
women, in order to reduce rates of discontinuation associated with the method.  
 
5.4.1 WOMEN’S PREFERENCE FOR INFORMATION 
According to Ntupanyama (2009), counseling is an interactive process in which a provider, in this 
instance, a midwife listens to clients’ concerns and provides useful information to allow them 
make informed decisions. In this study, participants reported their desire to get accurate 
information on amenorrhea from midwives. They expressed frustration at the tendency by some 
midwives to hide useful information that could help women use a chosen contraceptive method 
effectively. It should be highlighted that most participants felt that losing one’s menses was not 
normal. They were inclined to consider the cessation of menses as a panacea for any health 
anomaly they experience. Women opting for Depo-Provera are not counseled that if they use the 
method for a year or more there is a possibility of experiencing amenorrhea (Hodgins, 1999).  
When Depo-Provera users return to hospital or clinic distressed with a concern for amenorrhea, 
they are commonly explained to by providers that it was not a sickness, but it was the effect of the 
Depo-Provera. While some get reassured, many of them remain concerned (Hodgins, 1999). And 
this can lead to lack of trust towards family planning providers. As revealed by Hoggart and 
Newton (2013)in their qualitative study (N=20) on young women’s experiences of side effects 
resulting from contraceptive implants, the unwillingness by family planning providers to explain 
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all the side effects of Depo-Provera was against the wishes of young women’s desire for detailed 
information concerning the method. And this led to the distrust of the providers (Hoggart & 
Newton, 2013). 
As indicated earlier on, two participants returned to the clinic to complain that their menses had 
stopped. If midwives had counseled the participants initially, they would not have gone back to 
the clinic to complain about the cessation of menses. Good information could lead to better 
contraceptive options by women which in turn could increase contraceptive continuation rate. 
Women will continue using Depo-Provera if and only if they receive adequate information from 
providers (Ntupanyama, 2009). Cessation of menses is not viewed as normal unless one is pregnant 
or has reached menopause. According to Hodgins (1999) women are frequently asking: ‘if the 
blood is not coming out then where is it going, and what is it doing to the body?’ Thus, there is a 
need to offer proper and accurate information to women seeking contraceptive services.  
In a qualitative study (N=42) on women’s preferences for contraceptive counseling and decision 
making that was done in USA, Dehlendorf et al. (2013) indicated that one of the priorities for 
contraceptive users in their encounter with providers was understanding the information that was 
being given to them. Women appreciated having information on alternative contraceptive methods 
even though they came into the clinic with a preferential method they wanted to use (Dehlendorf 
et al., 2013). 
In their study, Jejeebhoy and Zavier (2012) found out that Depo-Provera users complained that 
information given by family planning providers was not comprehensive in many instances. While 
the users were informed were informed about the need for re-injections every three months and 
how the method works, less than three in five users had been informed about the potential side 
effect of amenorrhea and what to do if this side effect was experienced (Jejeebhoy & Zavier, 2012). 
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5.4.2 CONTROL OVER CONTRACEPTIVE DECISION MAKING BY MIDWIVES 
Two participants indicated that despite getting Depo-Provera they still felt that the decision to get 
the method was largely influenced by the midwives themselves. One participant indicated that in 
her encounter with a midwife Depo-Provera was mentioned several times or repeatedly with a 
view to entice her to get the injectable contraceptive.  According to her, it gave her the impression 
that other methods were not available when in actual fact they were available. Another participant 
indicated that sometimes providers wanted to give clients contraceptives that do not require much 
time to give when compared to those that need more time to be offered to one client such as 
implants. This was against the participants’ right to information that would enable them make 
informed choices on contraception. According to Hyttel et al. (2012), in their qualitative study on 
acceptability of Depo-Provera in Uganda revealed that family planning providers emphasized the 
importance of ensuring that women are able to make informed choice. 
In their qualitative study (N=42) on women’s preferences on contraceptive counseling and 
decision making, Dehlendorf et al. (2013) found out that the majority of women felt it was 
significant for them to make final decisions on which contraceptive methods they wanted to use. 
However, some of the women desired that family planning providers actively help them discuss 
their options by determining the best contraceptive choice on their behalf. About half of the 
participants indicated that in their most recent counseling by providers, it was the providers that 
chose specific preference that influenced their contraceptive option (Dehlendorf et al., 2013). This 
was consistent with what the two participants in this study experienced by stating that midwives 
played a big role in influencing them chose Depo-Provera. The providers did not provide all the 
information that could have made them make the right and independent choice.  
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According to Egarter et al. (2012) a comprehensive and well balanced contraceptive counseling 
pertaining to the pros and cons of the available family planning methods offers women wider 
options. This would make women reconsider their initial contraceptive choice in favor of a 
particular method that they did not know that it is available or exists, and which fits well with their 
medical and life style needs (Egarter et al., 2012).  
In their study, Hampton and McWatters (2003) family planning providers were considered as 
lacking knowledge about Depo-Provera. Some of the participants were of the view that providers 
encouraged them to start Depo-Provera without notifying them about the possibility of 
experiencing amenorrhea as a side effect, and for those that informed them did it inaccurately 
(Hampton & McWatters, 2003). The women stated that they were dissatisfied with not only the 
lack of knowledge by providers on Depo-Provera but also the tendency to coerce them to use the 
method without proving full information on side effects (Hampton & McWatters, 2003). 
 
5.5 AMENORRHEA NOT PERCEIVED AS A PROBLEM WHEN ADEQUATE 
INFORMATION IS PROVIDED BY MIDWIVES  
One out of the six participants shared a contrary experience of her encounter with a midwife at the 
family planning clinic. She stated that she was offered the necessary information for her to use 
Depo-Provera as her contraceptive method of choice. The woman explained that she did not 
perceive amenorrhea as a nuisance because the midwife at the clinic had already informed her that 
it was one of the side effects that she could anticipate while using the method. This was a different 
experience altogether as all the participants had indicated that they were not counseled on 
amenorrhea. 
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This was strength on the part of the midwives because the woman that was counseled did not have 
problems with amenorrhea when she experienced it. Due to the information she received she did 
not attach any beliefs to the amenorrhea as did other participants. She did not link her cessation of 
menses to pregnancy. There is need for providers to ensure that accurate information is provided 
to clients that could help make them continue using Depo-Provera as a contraceptive method. This 
will again help to lower the discontinuance rate that come mainly due to the occurrence of 
amenorrhea.   
In a qualitative analysis (N=50) of approaches to contraceptive counseling in the United States, 
Dehlendorf et al. (2014) stated that high quality interaction between a client and a family planning 
provider about contraception, particularly on side effects such as amenorrhea is associated with 
improvement in the use of Depo-Provera and other contraceptives. However, the researchers stated 
that little is known on how providers of contraceptives engage client or users in the decision 
making process. Client-provider interaction during visits to family planning clinic has a good 
influence on contraceptive use (Dehlendorf et al., 2014). Likewise, this study did not establish the 
extent to which one participant that was offered counseling was engaged in her interaction with 
the midwife.  However, it was appealing to learn that the midwife informed the participant on the 
possibility of amenorrhea in her use of Depo-Provera.  
 
5.6 CONCLUSION 
This chapter discussed the study findings in relation to relevant literature. The next chapter will 
focus on conclusion and recommendation.  
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CHAPTER 6 
CONCLUSION AND RECOMMENDATIONS 
6.0 INTRODUCTION 
This chapter presents the conclusion and recommendations based on findings of the study. The 
recommendations have been divided into two categories, which are recommendations related to 
nursing/ midwifery practice and policy.  The chapter extends to present the implications for further 
studies.  
 
6.1 CONCLUSION 
The aim of the study was to explore and describe women’s experiences of amenorrhea following 
use of Depo-Provera as a contraceptive method. This was achieved through the use of a qualitative 
design, in particular the phenomenological approach. The researcher bracketed his own 
experiences of working with family planning clients for about four years in his practice as a nursing 
and midwifery officer, as well as being a Malawian. 
There was limited literature specifically on women’s experiences of amenorrhea following the use 
of injectable Depo-Provera, and therefore the researcher utilized other related studies worldwide. 
It is also worth noting that the researcher did not find any study done in Malawi specifically on 
women’s experiences of amenorrhea following Depo-Provera use. 
The study has revealed that acceptors of Depo-Provera do not receive appropriate information 
concerning side effects, particularly amenorrhea which is a concern for most women. In the study 
participants highlighted that the injectable contraceptive was given to them without prior provision 
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of information concerning side effects. In their discussion, women expressed lack of knowledge 
on cause of amenorrhea which they experience while using Depo-Provera, and also fear of 
pregnancy while still on the method. One participant expressed the desire to discontinue using 
Depo-Provera since she considered cessation of her menstruation as unnatural, as she believed that 
when a woman stops menstruating then it is an indication that she is pregnant. The study also 
revealed that Depo-Provera was associated with various negative beliefs and rumors that had a 
negative impact on utilization of the method by women. 
The findings of the study have indicated poor counseling by family planning providers. Most of 
the women interviewed lamented that they received no family planning counseling during their 
encounter with a midwife. It was also evident from the findings that women were not actively 
involved in decision making regarding contraceptive choices. They expressed that providers 
sometimes decided on their behalf. 
However, it was of great interest to note that one of the respondents indicated that some providers 
do offer the information on the side effects of Depo-Provera. This highlighted that some of the 
providers discussed with clients the possibility of amenorrhea while using Depo-Provera. This 
gave women confidence when experiencing amenorrhea since they had already been informed that 
the phenomenon might happen to them in their course of using the method.   
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6.2 RECOMMENDATIONS 
6.2.1 RECOMMENDATIONS TO MIDWIFERY PRACTICE 
From the findings of the study it is recommended that: 
 There is need to improve method specific knowledge on a wide range of 
contraceptives on the part of providers, particularly midwives in order to address 
related safety concerns mainly on side effects. This will help providers ably and 
confidently counsel clients on adverse effects that come along with contraception. 
This will in turn improve utilization rate for contraceptives, and hence improve the 
contraceptive prevalence rate for the country. 
 There is need for midwife leaders to intensify their supervision on family planning 
providers to ensure that women are provided with proper and accurate information 
that will enable them not only to choose a birth control method but also enable them 
use the chosen method for a long time until such a time when they need another 
child. 
 There is need for family planning providers to dispel (through counseling) negative 
beliefs and myths surrounding the injectable Depo-Provera as this will contribute 
to high utilization rate for the method, and thus will contribute a great deal to the 
contraceptive prevalence rate. 
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6.2.2 RECOMMENDATIONS RELATED TO POLICY 
From the findings of the study it can be recommended that: 
 There is need for policy makers to devise strategies that will ensure that women 
and other family planning users are empowered to make their own decision in their 
choice of contraception every time they seek family planning services. 
 
6.3 IMPLICATIONS FOR FURTHER RESEARCH  
There is need to carry out further studies in nursing and midwifery on experiences of family 
planning providers in counseling women accepting Depo-Provera contraceptive method. This 
could help get the views of providers themselves in their encounter with acceptors of Depo-
Provera. There is also need to conduct a study on effect of cultural beliefs and misconceptions on 
uptake of Depo-Provera. This could help to examine the extent to which utilization of Depo-
Provera is affected by various cultural beliefs and misconceptions. 
 
6.4 CONCLUSION 
This chapter focused on conclusions and recommendations based on the findings of the study. The 
recommendations have been divided into two categories; those related to midwifery practice and 
those related to policy. The chapter also focused on implications for further research. 
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APPENDIX A 
PARTICIPANT INFORMATION SHEET (English Version) 
Title: Women’s Experiences of Amenorrhea following Depo-Provera use at a District 
Hospital in Malawi 
What is the purpose of the study? 
This research study is conducted by Boss Mwafulirwa as a requirement for the fulfilment of the 
Master’s Degree program at the University of the Western Cape. You are asked to participate in 
this research study since you will have a chance to share your experiences of amenorrhea following 
Depo-Provera use as a contraceptive method. The purpose of the study is to explore women’s 
experiences of amenorrhea following Depo-Provera use at Chitipa district hospital in Malawi. 
What am I expected to do in my participation in this study? 
You will be expected to attend an interview conducted by the researcher at your convenient place 
and time. The interview is expected to last for about 45- 60 minutes, and you will be required to 
share your experiences of amenorrhea following use of Depo-Provera as a family planning method. 
Is my participation in this study confidential?  
Your information provided for the sake of the study will be kept confidential by keeping it in a 
lockable cabinet. Codes, instead of names will used on the collected data. The interviews will be 
audio-recorded. In the final report, and in case of publication confidentiality will still be 
maintained. 
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Any risks in participating in the research study? 
Since the topic of research is sensitive, it may attract some emotions as regards your experiences, 
and in such a case, you will be referred to appropriate authorities for help, and the interview may 
be stopped. 
What are the benefits for taking part in the study? 
There are no personal gains, but the findings of the study have the potential to convey knowledge 
that will aid health care workers, particularly midwives and policy makers, to better understand 
women’s experiences of amenorrhea following Depo-Provera use. Information provided may also 
contribute to improved information or health education given to women. 
Any room for withdrawal in participating in the research study? 
Participation is strictly voluntary, and you are free to choose not to take part in the study. In the 
case that you have decided to take part in the study, you may as well feel free to withdraw 
participation at any point, and you will not lose any benefits for which you otherwise qualify. 
What action do I take if I have any question regarding the study? 
The researcher can be contacted at any time if there are any concerns pertaining to this research 
study by using the following contact information: Mobile- (+27) 745541738/ (+265) 993850381, 
email- 3413598@myuwc.ac.za. The research supervisor can also be contacted on the following 
numbers: +27718311185/0219599473. Email: nkwaleyela@uwc.ac.za. 
The permission to conduct the study has been granted by the Senate Research Committee and the 
Higher Degrees Committee of University of the Western Cape, as well as the National Health 
Sciences Research Committee of the Malawi Ministry of Health. 
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APPENDIX B 
PARTICIPANT INFORMATION SHEET (Tumbuka Version) 
VAKWENELA KUMANYA PA KAFUKUFUKU UYU 
MUTU WA KAFUKUFUKU: IVO WAZIMAYI WAKUKUMANA NAVO PALA 
WALEKA KUGEZA CHAKUMWEZI CHIFUKWA CHAKUGWIRISKA NTCHITO 
NTHOWA YA KUGWAZA YA DEPO-PROVERA 
Kasi chakulata cha kafukufuku uyu ni vichi? 
Kafukufuku uyu wakupangika na Boss Mwafulirwa, uyo wakupanga masambiro yake 
yakusazgirapo ku University of the Western Cape (UWC) mu chalo cha South Africa. 
Mukupempheka kutolapo lwande mu kafukufuku uyu kuti mulongosole umo mukukwaskikira pa 
umoyo winu pala mwaleka kugeza cha kumwezi chifukwa chakugwiriska ntchito nthowa ya kulera 
ya jekisoni, iyo zina lake ni Depo-Provera. Kafukufuku uyuwakukhwaska wazimayi awo 
wakupokera nthowa zawo zakulera kuchipatala cha boma la Chitipa. 
Kasi ine nitolengepo lwande uli mukafukufuku uyu? 
Mukupempheka kuzgola mafumbo agho mufumbikenge kukhwaskana na nthowa ya kulera ya 
Depo-Provera iyo mukugwiriska ntchito, ndipo vose ivi vizamutola mphindi zakukwana 45 mpaka 
60. 
Kasi kutolapo lwande kwane kuwenge kwachisisi? 
Vose ivo mudumbenge mwakuyana na kafukufuku uyu viwenge vachisisi ndipo vamusungikaso 
pa malo yakubisika, ndipo zina linu nalo likukhumbika yayi mukafukufuku uyu. Kwantheura 
manambala ndiyo yagwiriskikenge ntchito. 
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Pali nthangwanika zilizose izo zinganichitikila pakutolapo lwande mu kafukufuku uyu? 
Palije nthangwanika panyake vakofya vilivose kwakuyana nakafukufuku uyu. Ndipo pala chanthe 
ichi chingachitika tioneneseskenge kuti mwaovwirika mwakwenelera. 
Kasi uwemi wakutolapo lwande mu kafukufuku uwu nivichi? 
Palije kupindula kulikose pakutolapo lwande kwinu, kweni vilingwa vyakafukufuku uyu 
vizamovwira kuti wachipatala ntchito zawo izo wakovwiranazo imwe zilute munthazi kwakuyana 
naivo imwe mulongosolenge mukafukufuku uyu. 
Kasi nili naufulu wakukana kutolapo lwande mukafukufuku uyu? 
Kutolapo lwande linu mu kafukufuku uyu nkhwambula kuchichizgika, ntheura muli naufulu 
kukana kutolapo lwande mukafukufuku uyu. Kweniso mungamanya kulekezga panthowa 
nangawuli mwanguzomela kale kutolapo lwande ndipo palije chiheni chilichose icho 
chilondezgenge pachiganizo chinu chakulekera panthowa. 
Kasi pala nili na chakufumba panyake chilichose chakukhwaskana nakafukufuku uyu 
ningafumba njani? 
Niliwakunozgeka kuzgola mafumbo yinu nyengo iliyose, ndipo munganikhwaskaso 
pakuniyimbila foni pa manambala agha: +27745541738/+265993850381. Para ntchamachitiko 
mungamanyaso kulemba kalata nakutumizga ku email iyi: bmwafulirwa@yahoo.com. 
Mazaza yakupanga kafukufuku uyu yaperekeka kufuma ku Higher Degrees Committee kweniso 
Senate Research Committee yaku UWC uko nkhusambila. Kuno ku Malawi nazomerezgeka nawa 
National Health Sciences Research Committee kuti kafukufuku uyu wachitike. 
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APPENDIX C 
CONSENT FORM (English Version) 
Title: Women’s Experiences of Amenorrhea following Depo-Provera use at a District Hospital in 
Malawi 
I__________________, the participant have been proposed to take part in this research study 
currently being conducted by Boss Mwafulirwa, a Master’s Degree student at the University of 
the Western Cape. I have been assured by explanation that my identity will not be disclosed and 
that my taking part in the study is strictly voluntary. I have been told that I have the right to 
withdraw my participation at any time, and that such withdrawal will not be punitive on my part. 
The questions that I posed to the researcher were responded to appropriately. I have also been 
informed that even if the findings of the study are published anonymity will still be maintained. 
Information derived from the study will be confidential but accessible to the research supervisors, 
and submitted for a Master Degree. There is no personal, financial or other gain regarding my 
participation in this study. I have been told that the interview will be audio recorded and I have 
given permission for the recording to be done. 
I hereby, voluntarily give consent to take part in the study. 
Participant name: ___________________________ Date: _____________________  
Signature:  ____________________________  
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Statement by the Researcher: 
I__________________, the undersigned do hereby declare that I have explained the content of the 
document in English/Tumbuka to the participant, ____________________ (Name of participant) 
and requested her to ask questions if there is need for clarification. 
Researcher _______________________________ Date: ______________________ 
Signature: ____________________________  
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APPENDIX D 
CONSENT FORM (Tumbuka Version) 
CHIKALATA CHAKUZOMEREZGA KUTOLAPO LWANDE MU KAFUKUFUKU  
MUTU WA KAFUKUFUKU: IVO WAZIMAYI WAKUKUMANA NAVO PALA 
WALEKA KUGEZA CHAKUMWEZI CHIFUKWA CHAKUGWIRISKA NTCHITO 
NTHOWA YA KUGWAZA YA DEPO-PROVERA 
Ine ___________________________, napempheka kutolapo lwande mukafukufuku uyu 
wakupangiska Boss Mwafulirwa, msambili waku University of Western Cape (UWC). Naphalilika 
kuti vose ivo tidumbiranenge kukhwaskana nakafukufuku uyu viwenge vachisisi ndipo 
vamusungikaso malo yachisisi. Wanilongosoleraso kuti kweni asambizi wawo ndiwo 
wamuwonapo ivi nizgolenge mukafukufuku uyu, pakuti wamkhumbika kuti wapereke ku sukulu 
kwawo chifukwa ntchakwenerera kuti wamalizge sukulu iyo wakupanga. Waniphaliraso kuti 
nkhuchichizgika chara kutolapo lwande, kweniso kuti ningalekezga panthowa nangauli nazomera 
kale kutolapo lwande mukafukufuku uyu, ndipo kuti palije chiheni icho nichitilikenge pachifukwa 
chakuleka kutolapo lwande kwane. Mafumbo ghane yakukhwaskana nakafukufuku uyu agho 
nangufumba wanizgola makola ndipo mwakukholweska. Waniphaliraso uwemi wakafukufuku 
uyu, nakuti kwa ine pandekha palije phindu ilo nilisangenge mwaluwiro pakutolapo lwande kwane 
mu kafukufuku wangeti uyu. Kweni walongosola kuti vakusatila vya kafukufuku uyu vizamovwira 
kuti ntchito za chipatala zilute munthazi. Wanimanyiskaso kuti wajambulenge pa matepi ivyo 
nilongosolenge, ndipo ine nazomerezga kuti vichitike ntheura. 
Kwantheura nkhuzomerezga kutolapo lwande mu kafukufuku uyu mwachiganizo chakupanga pa 
ine ndekha. 
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Zina linu: ______________________________ Dazi: _______________________ 
Sayinani apa: _______________________ 
Uyo wakupangiska kafukufuku: 
Ine ________________________________ nkhuzomera kuti nalongosola vyose mwakuyana 
nakafukufuku uyu mu chiyowoyero chachitumbuka kwa ________________________ (zina la 
uyo wakutolapo lwande mukafukufuku uyu) ndipo namchiska kufumba mafumbo apo 
wangupulikiska chara. 
Zina: ___________________________       Dazi: _____________________________ 
Sayinani apa: ____________________ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
87 
 
APPENDIX E: 
INTERVIEW GUIDE 
English Version 
The following question will be asked: 
 Can you please tell me about your experiences of having amenorrhea following the use of 
Depo-Provera as a contraceptive method? 
Prompts and probes will follow depending on the responses to the above questions to elicit more 
information from participants. 
Tumbuka Version 
Fumbo ili ndilo lamufumbika: 
 Kasi munganilongosolerako na umo mukukwaskikira na kuleka kugeza chakumwezi 
chifukwa chakugwiriska ntchito jekisoni ya kulera ya Depo-Provera? 
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APPENDIX F 
LETTER REQUESTING PERMISSION TO CONDUCT STUDY AT CHITIPA 
DISTRICT HOSPITAL 
From: Boss Mwafulirwa 
           School of Nursing 
           University of the Western Cape 
           Private Bag 17, Bellville 
           South Africa. 
 
TO:   The District Health Officer 
          P.O. Box 95, Chitipa 
          Malawi 
 
Dear Sir, 
RE: APPLICATION FOR PERMISSION TO CONDUCT RESEARCH AT CHITIPA 
DISTRICT HOSPITAL 
 
I am a postgraduate student at the University of the Western Cape, reading a Master’s Degree in 
Nursing. As a requirement for the program, a student is supposed to conduct research. The title of 
my research is “Women’s Experiences of Amenorrhea following Depo-Provera use”. The overall 
purpose is to explore women’s experiences of amenorrhea following use of Depo-Provera as a 
contraceptive method at Chitipa District Hospital in Malawi. This is in order to gain a better 
understanding of how women experience amenorrhea following use of Depo-Provera and give 
meaning to the experience. 
I therefore, request for permission to conduct research (data collection) at your institution. I intend 
to interview 6 women who are attending family planning services at the clinic of the hospital. A 
report of the findings will be made available to your office after completion of the study. 
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Attached is a letter of ethical clearance from the Senate Research Committee of the University of 
Western Cape, and National Health Sciences Research Committee (NHSRC) of the Malawi 
Ministry of Health. 
 
Thanking you in advance. 
Yours sincerely, 
 
Boss Mwafulirwa 
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APPENDIX G 
QUALITATIVE RIGOR 
Extraction of significant statements 
Significant statements Transcript 
number 
Page 
number 
Lines 
number 
“I started using Depo-Provera in the year 2013, and soon 
after getting two injections of Depo-Provera I developed 
amenorrhea, and due to this I was so much devastated that I 
did not have peace in my mind”. 
1 1 1-5 
“In using this method I discovered that I started 
experiencing cessation of menses. Knowing that this 
problem started after using Depo-Provera I was very much 
worried”. 
2 1 3-7 
“Since I was not told at the time of starting the method, I 
went back to the hospital so that I can get tested to know if I 
am pregnant or not, and also that I should ask what I am 
experiencing because it was strange to me”. 
2 1 10-16 
“To my knowledge, when a woman or a girl stops 
menstruating it is a sign that she is pregnant”. 
2 1 16-18 
“I was surprised when I was told by the health worker that I 
am not pregnant but it is the injection of Depo-Provera that 
is making me stop menstruating. I did not believe since the 
2 1 19-26 
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doctor that initiated me on the method did not tell me about 
this effect of having ceased menstruation………..” 
“I was afraid because I believed that I was pregnant which 
was unplanned”. 
2 1 28-29 
“I had already been informed by other people that if one 
stops menstruating while using Depo-Provera injection it 
means the drug forms some solid particles inside the 
womb…..” 
2 2 9-13 
“……and that the bad blood that is supposed to be released 
during menstruation is retained inside the body, and which 
makes a woman stop child bearing…” 
2 2 13-17 
“At first I was surprised because to me it was my first time 
by then to use this method of family planning….” 
3 1 5-8 
“The major problem was that when I was starting the 
method the doctor did not explain to me anything, so when 
cessation of menses came I was worried since beginning my 
youthful days as a girl I have been menstruating 
properly….” 
3 1 10-16 
“I thought I have just developed some major problem in my 
life” 
3 1 16-17 
“I …..even started thinking as true what other women have 
been saying that when one is using Depo-Provera she stops 
getting pregnant again….” 
3 1 17-21 
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“…….. and some say the injection causes tumors in the 
womb that make a woman stop being fertile again”. 
3 1 21-24 
“When this problem of cessation of menses started, I and my 
husband were surprised and agreed that I should go back to 
the hospital to explain about my problem…” 
3 1 24-28 
“……because if there is no harm that they can do to our 
bodies these health workers would not be hiding from us 
such information”. 
3 2 23-26 
“Stopping to menstruate was a problem to me, ……..a big 
problem for that matter since what I know is that when one 
is pregnant it is the time she stops menstruating” 
3 2 27-31 
“In addition, when you are not menstruating it means the 
body is unable to get rid of contaminated blood”. 
3 2 32 
“……..and also that your fellow women stop to regard you 
as a woman”. 
3 3 2-4 
“Since such information is not shared to us by health 
workers I thought they do it deliberately fearing that if they 
tell us about the side effects of these family planning 
methods, most women would stop using them”. 
2 2 26-31 
“I thought they would give me tablets that would make me 
menstruate”. 
2 4 2-3 
“……people say that you can no longer get pregnant again 
if you are using an injection for family planning”. 
2 4 6-8 
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“…….because as a  woman or even my friends what we 
know is when one stops menstruating it means she is 
pregnant and that you will deliver a baby thereafter”. 
1 1 6-9 
“I did not have peace due to this cessation of menses….. I 
just thought that I am pregnant….” 
1 2 7-9 
“…….we got the injection of which we were not told on how 
it functions, and what we should anticipate while using the 
method”. 
1 3 20-23 
“I wanted to stop using Depo-Provera because of cessation 
of my menses I surely knew that it was coming due to the 
injection”. 
6 1 39-40 
“I was menstruating before using the method, so this was 
really a worry for me…..” 
6 2 3-5 
“Again at the hospital they just gave us the injection without 
explaining what would come after using the method”. 
6 2 13-16 
“The nurse explained to me how the injection works by 
saying that some women may experience heavy bleeding, 
some may have spotting, while some do stop having menses 
completely”. 
4 1 27-31 
“I was also told that if I stop menstruating it means that 
there is no problem and that women should not be worried 
about this…..it does not mean that a woman is pregnant”. 
4 2 6-13 
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“I did not worry much because I was already told at the 
hospital that this is what I may be experiencing if using the 
injection of Depo-Provera, and I was pretty sure that I am 
not pregnant as the nurse explained to me”. 
4 2 17-23 
“I did not regard amenorrhea as a problem because I was 
told about the effects at the hospital”. 
4 3 1-3 
“It is important that health workers should tell us the truth 
about methods of family planning, especially the injection 
because we hear a lot of negative stories from our friends”. 
5 1 1-5 
“The injection is a very good method only that it brings 
about cessation of menses…” 
5 1 5-7 
“……together with my husband I went to the hospital so that 
I can be tested to confirm If I am pregnant or not…” 
5 1 15-18 
“Even at the hospital we are not assisted since they hide 
useful information concerning family planning methods 
most especially Depo-Provera injection since it is the 
method most of us women like”. 
5 4 1-6 
“I got the injection because the nurse was mentioning it 
several times at the clinic that it was the only one 
available…” 
6 2 23-26 
“It seems they themselves have methods in mind that they 
want us to get without our informed consent”. 
1 3 3-5 
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Formulation of meanings from significant statements 
Significant statement Formulated Meanings 
“I started using Depo-Provera in the year 
2013, and soon after getting two injections of 
Depo-Provera I developed amenorrhea, and 
due to this I was so much devastated that I did 
not have peace in my mind”. (Transcript 1, 
page 1, lines 1-5) 
Participant expressed worry after noticing that 
her menses had ceased as she was not told 
about the side effects of Depo-Provera. 
“In using this method I discovered that I stated 
experiencing cessation of menses knowing that 
this problem started after I started using Depo-
Provera I was very much worried”. 
(Transcript 2, page 1, lines 3-7) 
Participant was worried when she discovered 
that she is no longer menstruating which she 
strongly suspected was due to use of Depo-
Provera despite not being told by midwives at 
the clinic. 
 
“Since I was not told at the time of starting the 
method, I went back to the hospital so that I 
can get tested to know if I am pregnant or not, 
and also that I should ask what I am 
experiencing because it was strange to me”. 
(Transcript 2, page 1, lines 10-16) 
Participant linked her experience of cessation 
of menses to being pregnant since she had no 
idea that it was the effect of Depo-Provera. 
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“To my knowledge, when a woman or a girl 
stops menstruating it is a sign that she is 
pregnant”. (Transcript 2, page 1, lines 16-18) 
Participant indicated that when a woman loses 
her menses then it means that she is pregnant. 
“I was surprised when I was told by the health 
worker that I am not pregnant but it is the 
injection of Depo-Provera that is making me 
stop menstruating. I did not believe since the 
doctor that initiated me on the method did not 
tell me about this effect of having ceased 
menstruation………..” (Transcript 2, page 1, 
lines 19-26) 
Participant did not believe the midwife after 
she was told that she was not pregnant as she 
was not told at first about the effect of 
amenorrhea coming as a result of using Depo-
Provera. 
“I was afraid because I believed that I was 
pregnant which was unplanned”. (Transcript 
2, page 1, lines 28-29) 
Participant expressed fear of getting an 
unplanned pregnancy. 
“I had already been informed by other people 
that if one stops menstruating while using 
Depo-Provera injection it means the drug 
forms some solid particles inside the 
womb…..” (Transcript 2, page 2, lines 9-13) 
Participant was convinced that Depo-Provera 
is harmful since it leads to formation of solid 
particles in the womb. 
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“……and that the bad blood that is supposed 
to be released during menstruation is retained 
inside the body, and which makes a woman 
stop child bearing…” (Transcript 2, page 2, 
lines 13-17) 
Participant shared the belief that Depo-Provera 
leads to accumulation of contaminated blood 
in the body since it causes amenorrhea. 
“At first I was surprised because to me it was 
my first time by then to use this method of 
family planning….” (Transcript 3, page 1, 
lines 3-5) 
Participant was ignorant of the amenorrhea 
since it was her first time to use the method. 
“The major problem was that when I was 
starting the method the doctor did not explain 
to me anything, so when cessation of menses 
came I was worried since beginning my 
youthful days as a girl I have been 
menstruating properly….” (Transcript 3, page 
1, lines 10-16) 
Participant indicated to have a big problem 
upon her life due to the developing amenorrhea 
since she was not counselled at the time of 
getting the injection and considering that all 
along she has been having her menses. 
“I …..even started thinking as true what other 
women have been saying that when one is 
using Depo-Provera she stops getting 
pregnant again….” (Transcript 3, page 1, lines 
17-21) 
Participant indicated that people believe that 
using Depo-Provera would lead to loss of 
fertility in the woman’s life time. 
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“…….. and some say the injection causes 
tumors in the womb that make a woman stop 
being fertile again”. (Transcript 3, page 1, 
lines 21-24) 
Participant shared the belief that women think 
that Depo-Provera leads to tumor growth in the 
womb which later causes infertility. 
“When this problem of cessation of menses 
started, I and my husband were surprised and 
agreed that I should go back to the hospital to 
explain about my problem…” (Transcript 3, 
page 1, lines 24-28) 
Participant explained that she went back to 
hospital after developing amenorrhea since she 
did not know what it was, therefore she needed 
attention of midwives. 
“……because if there is no harm that they can 
do to our bodies these health workers would 
not be hiding from us such information”. 
(transcript 3, page 2, lines 23-26) 
Participant expressed the idea that midwives 
hide information on side effects since they 
know that it is harmful to women’s bodies. 
“Stopping to menstruate was a big problem to 
me, ……..a big problem for that matter since 
what I know is that when one is pregnant it is 
the time she stops menstruating” (Transcript 
3, page 2, lines 27-31) 
Participant considered her amenorrhea as a 
sign that she was pregnant since she was not 
told that Depo-Provera could also bring about 
amenorrhea 
“In addition, when you are not menstruating it 
means the body is unable to get rid of 
contaminated blood”. (Transcript 3, page 2, 
lines 32) 
Participant thought that amenorrhea leads to 
retention of contaminated blood in the body. 
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“……..and also that your fellow women stop to 
regard you as a woman”. (Transcript 3, page 
3, lines 2-4) 
Participant expressed worry that if using Depo-
Provera and thereafter develops amenorrhea, 
other women mock them as not being real 
women. 
“Since such information is not shared to us by 
health workers I thought they do it deliberately 
fearing that if they tell us about the side effects 
of these family planning methods, most women 
would stop using them”. (Transcript 2, page 2, 
lines 26-31) 
Participant indicated that midwives do not 
counsel them about the effects of using Depo-
Provera on their bodies fearing that they would 
stop using the injection. 
“I thought they would give me tablets that 
would make me menstruate”. (Transcript 2, 
page 4, lines 2-3) 
Participant indicated that she went back to the 
clinic to get tablets in order to bring back her 
menses. 
“……people say that you can no longer get 
pregnant again if you are using an injection for 
family planning”. (Transcript 2, page 4, lines 
6-8) 
Participant indicated that what people knows is 
that Depo-Provera leads to inability to get 
pregnant again. 
“…….because as a  woman or even my friends 
what we know is when one stops menstruating 
it means she is pregnant and that you will 
deliver a baby thereafter”. (Transcript 1, page 
1, lines 6-9) 
Participant explained that amenorrhea coming 
due to use of Depo-Provera is mostly linked to 
pregnancy since they are not told about side 
effects of this injectable contraceptive. 
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“I did not have peace due to this cessation of 
menses….. I just thought that I am 
pregnant….” (Transcript 1, page 2, lines 7-9) 
Despite using Depo-Provera, participant 
thought that she was pregnant since she had no 
knowledge as to why she was experiencing 
cessation of menses. 
“…….we got the injection of which we were 
not told on how it functions, and what we 
should anticipate while using the method”. 
(Transcript 1, page 3, lines 20-23) 
Participant indicates that despite being 
initiated on Depo-Provera she received no 
counseling on the method; adverse effects that 
could come due to Depo-Provera use. 
“I wanted to stop using Depo-Provera because 
of cessation of my menses I surely knew that it 
was coming due to the injection”. (Transcript 
6, page 1, lines 39-40) 
In realizing that that her menses had ceased 
participant wanted to stop using Depo-
Provera; she did not like the amenorrhea. 
“I was menstruating before using the method, 
so this was really a worry for me…..” 
(Transcript 6, page 2, lines 3-5) 
Participant was worried due to development of 
amenorrhea as a result of using Depo-Provera. 
“Again at the hospital they just gave us the 
injection without explaining what would come 
after using the method”. (Transcript 6, page 2, 
lines 13-16) 
Participant explained that she was not 
counselled on Depo-Provera, especially what 
adverse effects would come afterwards. 
“The nurse explained to me how the injection 
works by saying that some women may 
experience heavy bleeding, some may have 
Participant indicated that while at the hospital 
the midwife explained to her what effects 
would come while using Depo-Provera. 
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spotting, while some do stop having menses 
completely”. (Transcript 4, page 1, lines 27-
31) 
“I was also told that if I stop menstruating it 
means that there is no problem and that women 
should not be worried about this…..it does not 
mean that a woman is pregnant”. (Transcript 
4, page 2, lines 6-13) 
Participant expressed that the midwife 
reassured her that even if she was going to 
experience amenorrhea while using Depo-
Provera it could not mean that she was 
pregnant. 
“I did not worry much because I was already 
told at the hospital that this is what I may be 
experiencing if using the injection of Depo-
Provera, and I was pretty sure that I am not 
pregnant as the nurse explained to me”. 
(Transcript 4, page 2, lines 17-23) 
Participant explained that amenorrhea was not 
a problem to her since she was already 
informed about it. 
“I did not regard amenorrhea as a problem 
because I was told about the effects at the 
hospital”. (Transcript 4, page 3, lines 1-3) 
Participant explained that while at the hospital 
the midwife explained to her what effects 
would come while using Depo-Provera. 
“It is important that health workers should tell 
us the truth about methods of family planning, 
especially the injection because we hear a lot 
of negative stories from our friends”. 
(Transcript 4, page 3, lines 21-25) 
Participant pleaded with midwives to be on the 
fore front in sharing information on Depo-
Provera since there are a lot of negative stories 
concerning the method. 
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“The injection is a very good method only that 
it brings about cessation of menses…” 
(Transcript 5, page 1, lines 5-7) 
Participant expressed her dislike for loss of her 
menstruation due to Depo-Provera use. 
“……together with my husband I went to the 
hospital so that I can be tested to confirm If I 
am pregnant or not…” (Transcript 5, page 1, 
lines 15-18) 
Participant explained that she went back to the 
clinic with her husband so that she can be 
offered a pregnancy test to confirm if she was 
pregnant. 
“Even at the hospital we are not assisted since 
they hide useful information concerning family 
planning methods most especially Depo-
Provera injection since it is the method most of 
us women like”. (Transcript 5, page 4, lines 1-
6) 
Participant registered her frustration at 
midwives for not providing them with useful 
information on Depo-Provera despite the 
method being liked by women. 
“I got the injection because the nurse was 
mentioning it several times at the clinic that it 
was the only one available…” (Transcript 6, 
page 2, lines 13-16) 
Participant indicated that the midwife 
repeatedly mentioned about Depo-Provera in 
order to entice her to get the method. 
“It seems they themselves have methods in 
mind that they want us to get without our 
informed consent”(Transcript 1, page 3, lines 
3-5) 
Participant explained that midwives 
sometimes coerce women to opt for a 
contraceptive they do not want. 
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Formation of themes 
Formulated meaning Sub-theme Main theme 
Participant was worried when 
she discovered that she is no 
longer menstruating which 
she strongly suspected was 
due to use of Depo-Provera 
despite not being told by 
midwives at the clinic. 
Participant was worried due to 
the development of 
amenorrhea. 
Participant expressed worry 
after noticing that her menses 
had ceased as she was not told 
about the side effects of Depo-
Provera. 
Worry over Depo-Provera 
induced amenorrhea 
Lack of knowledge on cause 
of amenorrhea. 
In realizing that her 
menstruation had stopped, 
participant wanted to stop 
using Depo-Provera. 
Discontinuing Depo-Provera 
due to amenorrhea 
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Participant indicated that she 
went back to the clinic to get 
tablets to bring back her 
menses. 
Participant considered her loss 
of menstruation as a sign that 
she was pregnant. 
Participant explained that 
when a woman loses her 
periods then it means that she 
is pregnant. 
Participant explained that she 
went back to the hospital after 
developing amenorrhea since 
she did not know what it was, 
and therefore needed the 
attention of midwives. 
Participant expressed fear of 
getting an unplanned 
pregnancy. 
Participant explained that she 
did not believe the midwife 
 Fear of pregnancy 
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when she was told that she 
was not pregnant since she 
was not told about any effect 
of using Depo-Provera. 
Participant was concerned that 
Depo-Provera was harmful 
since it leads to formation of 
solid particles in the womb. 
Participant expressed the view 
that amenorrhea leads to 
retention of contaminated 
blood in the body. 
Participant expressed fear that 
Depo-Provera leads to 
accumulation of contaminated 
blood in the body since it 
caused amenorrhea. 
Participant indicated that 
people believe that using 
Depo-Provera would lead to 
loss of fertility in the woman’s 
life time. 
Fear of infertility 
 
 
 
 
 
 
 
 
 
 
 
 
Failure by midwives to dispel 
myths, rumors and beliefs 
concerning amenorrhea 
resulting from Depo-Provera 
use. 
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Participant shared the belief 
that Depo-Provera leads to 
tumor growth in the womb 
which later causes infertility. 
Participant indicated that what 
people knows is that Depo-
Provera leads to inability to 
get pregnant again. 
Participant expressed the idea 
that midwives hide 
information on side effects 
since they know that Depo-
Provera is harmful to 
women’s bodies. 
Participant explained that 
midwives do not counsel them 
on the effects of using Depo-
Provera on their bodies 
fearing that they would stop 
using the method. 
Participant pleaded with 
midwives to be on the fore 
Women’s preference for 
information. 
Lack of proper counseling on 
amenorrhea resulting from 
Depo-Provera use. 
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front in sharing information 
on Depo-Provera since the 
method the method is 
associated with a lot of 
negative stories. 
Participant registered her 
frustration at midwives for not 
providing them with accurate 
information on Depo-Provera 
despite the method being liked 
by most women. 
Participant explained that she 
was not counseled on Depo-
Provera, especially on what 
side effects could come after 
using the method. 
Participant was ignorant of the 
amenorrhea being 
experienced since it was her 
first time to use the method. 
Participant explained that 
midwives sometimes coerce 
Control over contraceptive 
decision making by midwives. 
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clients to opt for a 
contraceptive which they did 
not want. 
Participant indicated that the 
midwife repeatedly 
mentioned about Depo-
Provera in order to entice her 
to get the method. 
Participant explained that 
amenorrhea was not a problem 
to her since she was already 
informed about it. 
Participant indicated that 
ceased menstruation was not 
an issue since she had been 
informed at the clinic that it 
does not mean that a woman is 
pregnant if she was going to 
experience it while using 
Depo-Provera. 
Participant explained that 
while at the hospital the 
 Amenorrhea not perceived as 
a problem when midwives 
provide adequate information. 
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midwife told her what side 
effects would come while 
using Depo-Provera. 
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APPENDIX H: ETHICS CLEARANCE LETTER FOM UWC
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APPENDIX I: APPROVAL LETTER FROM RESEARCH SETTING 
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APPENDIX J: APPROVAL LETTER FROM NHSRC (MALAWI) 
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APPENDIX K: THESIS CORRECTIONS-  
Proposed changes and action taken by student researcher 
Thesis Title: Women’s Experiences of Amenorrhea following Depo-Provera Use at a District 
Hospital in Malawi 
Student Researcher: Boss Mwafulirwa         Student Number: 3413598  
Research Supervisor: Prof. Elizabeth Swart                                       
Department: School of Nursing, University of the Western Cape 
 
Page 
number 
Proposed changes Action taken by student 
xi  Key word “Counseling” changed to 
Contraception counseling- see under 
Operational definitions 
x Missing Abbreviations ICF & UNICEF included in the list of 
abbreviations- see under list of 
abbreviations. 
xiii 12-week interval (Abstract) Now changed to 12-weeks interval- 
see under Abstract 
xiii Theme three was long Now it reads “Misconceptions 
associated with Depo-Provera 
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Induced Amenorrhea”- see under 
Abstract 
2 12-week Now it reads 12-weeks- see section 
1.0 
2 Halting implantation of fertilized ova Halting implantation of the fertilized 
ova- see section 1.0 
2-3 Statistics Some statistics added to Introduction 
and Background- see section 1.0  
3  New reference added due to inclusion 
of some statistics: (NSO & UNICEF, 
2008)- see section 1.0 
3 (MOH, 2012) not in reference list (MOH, 2012) has been included in 
the reference list- see in Reference 
list 
4 Problem statement Added information to make it 
Malawi-focused- see section 1.1 
5 Operational definitions lacking 
references 
References have been included in the 
operational definitions- see section 
1.6 
6 World Bank (2012) World Bank report of 2012 (as cited 
in NSO & ICF Macro, 2011)- see 
section 1.7.1 
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6 Government of Malawi/Malawi 
Government- lacking consistency 
Malawi Government; maintained 
throughout the document- see section 
1.7.1, and has been included in the 
reference list- see reference list 
7 (NSO & ICF Macro 2011) (NSO & ICF Macro, 2011)- see 
section 1.7.1 
9  Some statistics added- see section 
1.7.2.1 
9 Figure2: Map of Health Facilities in 
Chitipa- Source lacking 
Source has been included 
13-14 Literature review lacking detail More information added in the 
literature review- see section 2.2 
13 Foreman & Spieler (2013) Foreman and Spieler 2013- see 
section 2.2 
13 (WHO 1981)- lacking a comma (WHO, 1981)- see section 2.2 
15 Literature review  Information added under literature 
review- see section 2.3 
15 Fisher & Black (2007) Fisher and Black (2007)- see section 
2.3 
16-17 Literature review Information added to improve 
literature review- see section 2.3 
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18 Qualitative Research Approach should 
come before Research Design 
Qualitative Research Approach has 
been put first followed by Research 
Design- see sections 3.2 & 3.2 
19 Edward Husserl Edward Husserl (2012)-see section 
3.2.1 
19 Wojnar & Swanson (2007) 
Starks & Trinidad (2007) 
Wojnar and Swanson (2007)- see 
section 3.2.1 
Starks and Trinidad (2007)- see 
section 3.2.1 
20 Polit & Beck (2012) Polit and Beck (2012)- see section 
3.5 
21  Some information added on 
Population, section 3.4 
22 Brink & Brink (2012) Brink & Brink (2012)- see section 
3.2.1 
22 Bracketing Information added, especially to 
expand on Bracketing- see section 
3.5.1 
23 Burns, Grove, & Gray (2013) not in 
Reference list 
It has been included in the reference 
list- see section 3.5.1 & 3.5.2 
23 Exclusion sampling criteria Information added on Exclusion 
sampling Criteria- see section 3.5.2 
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25 Field notes were recorded Information added to explain on this- 
see section 3.7 
26 Corbin & Strauss (2014, p.1) 
 
 
Colaizzi’s method 
Corbin and Strauss (2014:1)- see 
section 3.8 
 
Reference included-(as cited in 
Shosha, 2012)- see section 3.8 
28 Appendix J Appendix G- see section 3.8 
29 (Speziale, Streubert, Carpenter & 
Rinaldi 2007)- comma lacking 
(Speziale, Streubert, Carpenter, & 
Rinaldi, 2007)- see section 3.9 
31 Fouka & Mantzorou (2011) Fouka and Mantzorou (2007)- see 
section 3.10.1 
34  Sentence written appropriately- see 
section 4.1  
39 Theme three too long  Theme three: now reads 
“Misconceptions associated with 
Depo-Provera Induced Amenorrhea”- 
see section 4.5 
46 The website reference  It has been removed and replaced 
with another one (Diamond-Smith et 
al., 2011). Some information have 
been added too- see section 4.8.1 
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46 
 
47 
Client replace with patient 
 
Alaii, Nanda, & Njeru, 2012) 
Now it reads patient- see section 
4.8.1 
Alaii et al., 2012 (Second reference 
including three authors)- see section 
4.8.1 
49 Repta & Clarke (2013) Repta and Clarke (2013)- see section 
5.1.1 
50 De Cetina, Canto, & Luna (2001) De Cetina, Canto, and Luna (2001)- 
see section 5.1.2 
52 Jejeebhoy & Zavier (2012) 
 
Cheung & Free (2005) 
Jejeebhoy and Zavier (2012)- see 
section 5.1.2 
Cheung and Free (2005)-see section 
5.2 
53 Jejeebhoy & Zavier (2012) 
 
Hampton & Mc Watters (2003) 
Jejeebhoy and Zavier (2012)- see 
section 5.2 
Hampton and Mc Watters (2003)- 
see section 5.2 
53 Theme Three too long Theme Three now reads 
“Misconceptions Associated with 
Depo-Provera induced amenorrhea”- 
see section 5.3 
54 Chap & Escoffier (1996) 
Hampton & Mc Watters (2003) 
Chap and Escoffier (1996)- see 
section 5.3 
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Hampton and Mc Watters (2003)- 
see section 5.3 
55 Chap & Escoffier (1996) Chap and Escoffier (1996)- see 
section 5.3.1 
57 Hoggart & Newton (2013) Hoggart and Newton (2013)- see 
section 5.4.1 
58 Jejeebhoy & Zavier (2012) 
 
Jejeebhoy & Zavier (2012) 
Jejeebhoy and Zavier (2012)- see 
section 5.4.1 
Jejeebhoy and Zavier (2012)- see 
section 5.4.1 
60 Hampton & Mc Watters (2003) Hampton and Mc Watters 92003)- 
see section 5.4.2 
66  Adetunji, J.A. (2013)- Journal 
lack 
 
 Bagade, O., Pawar, R., Patel, 
B., Awasarkar, V., & Diwate, 
S. (2014)-Journal lack 
Journal included- see in reference 
list 
 
Journal included- see in reference 
list 
67 Burns, et al. (2013) not in reference 
list 
Included in the reference list- see 
reference list 
67 Carneiro Ferreira, A.L., Impieri 
Souza, A., Evangelista Pessoa, R., & 
Braga, C. (2011)-  
Included in reference list due to 
additional information in literature 
review section- see reference list 
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69 De Vos, A.S. (2011) Now well-spaced- see reference list 
69 Spacing between Do Amaral and 
Edwards and Egarter 
The spacing has been corrected, now 
spacing at 2.0 from one reference to 
the next- see reference list 
70 Foreman, M., & Spieler, J. (2013)- 
Journal lack 
Journal has been included to the 
reference- see reference list 
70 Fouka, G. & Mantzorou, M. (2011)- 
Journal lack 
Journal has been included to the 
reference- see reference list 
70 Gemzell-Danielsson, K., Inki, P., 
Mansour, D., Reid, R., & 
Bahamondes, L. (2012) 
Included in the reference list due to 
the additional information added in 
literature review- see reference list 
71 Hampton, M. & Mc Watters, B. 
(2003)- Journal lack  
Journal included to the reference. 
And “a” removed since the letters are 
used when the same authors 
published two different materials in 
the same year- see reference list 
71 Harper, C.C., Stratton, L., Raine, T.R., 
Thompson, K., Henderson, J.T., Blum, 
M., Postlethwaite, D., & Speidel, J.J. 
(2013) 
It has been included in the reference 
list due to additional information in 
literature review-see reference list 
71 Hodgins, S. (1999)- Journal lack Journal name included to the 
reference- see reference list 
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72 Husain, Z., Dutta, M., & Ghosh, S. 
(2011)-Journal lack 
Journal name has been added to the 
reference- see reference list 
72 Jejeebhoy, S.J., & Zavier, A.F. 
(2012)- Journal lack 
Journal name included to the 
reference- see reference list 
72 Jaccard, J. & Levitz, N. (2013) The reference has been included due 
to additional information in literature 
review-see reference list 
73 Kittisiam, T., Werawatakul, Y., 
Nanagara, R., & Wantha, O. (2013) 
The reference has been included due 
to additional information in 
operational definitions- see reference 
list 
73 Lemma, V.M., Mtimavyale, L.A. & 
Gondwe, E.F. (1994). 
Included in reference list due to 
additional information in Problem 
statement-see reference list 
73 Madden, T., Mullersman, J.L., Omvig, 
K.J., Secura, G.M., & Peipert, J,F. 
(2013) 
Included due to additional 
information in literature review- see 
reference list 
74 MDHS (2010) Included in reference list-see 
reference list 
74 Malawi Government (2012) Included in reference list- see 
reference list 
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75 NSO & UNICEF (2008) Included due to additional 
information in literature review- see 
reference list 
75 NSO & ICF International (2016) Included due to additional 
information in Introduction and 
Background- see reference list 
75 Nobili, M.P., Piegrossi, S. Brusati, V., 
& Moja, E.A. (2007) 
Included in reference list due to 
additional information in literature 
review- see reference list 
76 Russell Bernard, H. (2002)- Publisher Publisher has been added to the 
reference- see reference list 
76 EMHJ (Journal name not written in 
full) 
Journal name has been written out in 
full- see reference list 
77 Smythe, E. (2011)- Journal lack Journal included to the reference- see 
reference list 
77 Speziale, H. & Carpenter, D. R. 
(2007) 
There are only two authors, hence the 
use of “&”- see reference list 
78 Weinreb, A. (2013) Included due to additional 
information added in literature 
review- see reference list 
78 Wellons, M.F. & Rebar, R.W. (2013) Included due to additional 
information in operational 
definitions- see reference list 
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111 Appendix H: Ethics Clearance from 
UWC 
Included in the main document- see 
Appendix H 
112 Appendix I: Approval letter from 
Research Setting 
Included in the main document- see 
Appendix I 
113 Appendix J: Approval letter from 
NHSRC 
Included in the main document- see 
Appendix J 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
